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CHAPTER 1 
INTRODUCTION 
1 
INTRODUCTION 
von Economo's finding in 1929 on sleeping sickness was 
the first milestone in understanding of the hypothalamus in 
the regulation of sleep. The importance of preoptic area in 
the induction of sleep, in animals, were later experimentally 
substantiated by many studies (Benedek et al., 1979; Nauta, 
1946; Sterman and Clemente, 1962). This area receives 
afferent noradrenergic fibres from the brainstem (Anden et 
al., 1966; Palkovits et al., 1974; Swanson and Hartman, 
1975). The terminals of noradrenergic fibres have been shown 
to be present in the medial preoptic area (mPOA) by 
histofluorescence and spectrophotometric techniques (Anden et 
al., 1966; Ungerstedt, 1971a). Increased wakefulness produced 
by destruction of noradrenergic fibres in the medial preoptic 
area indicate that these fibres may have a hypnogenic role 
(Mohan Kumar et al., 1993). On the other hand, injection of 
norepinephrine (NE) and its antagonists, phenoxybenzamine and 
phentolamine, at the raPOA, produced arousal and sleep 
respectively, suggesting its possible involvement in arousal 
or wakefulness (Datta et al., 1988; Mohan Kumar et al., 
1984). These contradictory observations call for further 
investigations into the site of actions of these locally 
injected adrenergic agents and the receptors involved in 
these responses. NE injected at the mPOA could be acting, 
either at the presynaptic, or the postsynaptic receptors. To 
find out the role of the postsynaptic adrenoceptors (which 
are predominantly of alpha-1 type) , NE was injected at the 
mPOA, after destroying the adrenergic fibre terminals which 
have the presynaptic receptors (Mohan Kumar et al., 1993). 
This resulted in hypnogenesis, indicating that in normal 
animals, the externally applied NE, which produced arousal, 
may not be acting predominantly on the postsynaptic alpha-1 
receptors. On the other hand, its main action may be at the 
presynaptic alpha-2 receptors. The present study was 
undertaken to find out the specific role of alpha-2 receptors 
at the mPOA in the regulation of sleep-wakefulness in rats. 
CHAPTER 2 
REVIEW OF LITERATURE 
REVIEW OF LITERATURE 
The preoptic area has been extensively studied in a 
variety of mammals including the mouse (Broadwell and Bleier, 
1976), rat (Gurdjian, 1927; Conrad and Pfaff, 1974 , 1976a, 
b; Swanson, 1976a; Ambach et al., 1978; Bleier et al., 1979), 
opossum (Loo, 1931), bat (Humphrey, 1936), and monkey (Papez 
and Aronson, 1934; Atlas and Ingram, 1937). 
MORPHOLOGY AND ANATOMY OF THE PREOPTIC AREA l 
The mPOA is rostrally bounded by the nuclei of the 
diagonal band of Broca and accumbens. Caudally its border is 
not well defined and is continuous with the anterior 
hypothalamic region. Medially, it is delimited by the third 
ventricle and laterally by the anterior amygdaloid area. 
Dorsally, it is related to anterior commissure and ventrally 
to the optic chiasma. It is considered to be derived 
embryologically from unevaginated telencephalon medium (His, 
1893; Clark, 1938; Swanson, 1976a). 
Morphologically the rostral hypothalamus and the 
preoptic region are inseparable which has given birth to the 
belief amongst some workers that the POA may be a 
hypothalamic derivative, arising caudal and ventral to the 
lamina terminalis and the commissural plate (Rose, 1935, 
1942; Kuchlenbenck, 1954). 
In rat, the POA is a small area in the basal forebrain, 
measuring less than 1.5 mm in the rostro-caudal extent 
(Swanson, 1976). The POA can be divided cyto-
architectonically into three zones, a) lateral b) medial and 
c) periventricular (Gurdjian, 1927; Swanson, 1976; Bleier et 
al., 1979). The three zones are described in detail below : 
(a) Lateral zone; 
The lateral POA is characterized by medium sized 
neurons, scattered among the fibres of a conspicuous 
dorsomedial division of the medial forebrain bundle 
(Gurdjian, 1927; Swanson, 1976; Bleier et al., 1979). The 
central parts of this area is called pars preoptica of medial 
forebrain bundle. The medial part contains fibres and many 
neurons, and is called the lateral preoptic nucleus 
(Gurdjian, 1927; Jacobowitz and Palkovits, 1974; Swanson, 
1976; Bleier et al., 1979). Lateral preoptic zone merges 
medially with the medial POA and caudally with the lateral 
hypothalamic area without any clear cut demarcation. 
Rostrally, it is delimited by the diagonal band of Broca and 
nucleus accumbens septi. Dorsally, it is separated from the 
bed nucleus of stria terminals by a thin layer of relatively 
cell free zone (Swanson, 1976). 
(b) Medial Zone; : 
The medial zone consists of loose, heterogeneous, 
medium sized and relatively densely packed neurons and 
appears to be free of fibres. It is limited dorsally by the 
anterior commissure and ventrally, by the optic chiasma. 
Medially, it is well defined with periventricular nucleus. 
Laterally, it merges with lateral POA without any clear cut 
demarcation. Caudally, it merges with the less cell dense, 
anterior hypothalamic area. Rostrally , it is confluent with 
the septum and the basomedial aspect, with the diagonal band 
and its nucleus. The nucleus of stria terminals is wedged 
between the lateral and medial POA dorsally. In this region, 
densely grouped column of small round cells run along the 
ventral part of the third ventricle, immediately, caudal to 
the lamina terminals and preoptic periventricular nucleus 
called medial preoptic nucleus (Bleier et al., 1979). 
(c) Periventricular zone; 
This is a thin region of cells lining, and often 
oriented parallel to the third ventricle. Preoptic 
periventricular nucleus is a collection of small densely 
grouped cells, which is most prominent rostral to the third 
ventricle. As the ventricle and the lamina terminals appear, 
the periventricular nucleus turns laterally and a pair of 
prominent bar like collection of cells are seen as part of 
its ventral extremity. Caudal to this level, the preoptic 
periventricular nucleus cells are loosely grouped and finally 
succeeded by the periventricular cells of the anterior 
hypothalamic area (Swanson, 1976, Bleier et al., 1979). 
The description so far attributed of the POA is as 
seen by gross examination and light microscopy. Further 
anatomical information regarding the functional importance, 
has been gained from histochemical and biochemical studies of 
neurotransmitters present in this area. 
NOREPINEPHRINE SYSTEM IN RAT BRAIN 
The mPOA contains neurotransmitters like norepinephrine 
(NE), dopamine (DA), serotonin (5HT) and acetylcholine (ACh). 
These neurotransmitters mediate various functions such as 
temperature regulation, sex behaviour and maternal behavior 
including the regulation of sleep-wakefulness. 
Noradrenergic system j_ 
Histofluroscence and spectrophoto-fluoremetric 
techniques have shown that noradrenergic fibres are present 
in the mPOA (Anden et al., 1966; Ungerstedt, 1971a; Jonsson 
et al., 1972; Bjorklund et al., 1973, Martinovic and McCana, 
1977; Nicholson et al., 1978). This has been further 
substantiated by immunoflurescence technique which is more 
sensitive (Swanson and Hartman, 1975; Kizer et al., 1976). 
Moderate amounts of NE has been shown by radio isotope method 
(Kobayashi et al,, 1974; Palkovits et al., 1974; Versteeg et 
al., 1976; Hohn and Wuttke, 1978). Also 6-hydroxydopamine 
(6-OHDA) has been used as a tool, in the mapping of central 
NE pathways (Jacobowitz and Kostrzewa, 1971; Sachs and 
Jonsson, 1972). 
Using the above mentioned techniques, several ascending 
and descending noradrenergic pathways have been identified 
in the brain stem of rat (Ungerstedt, 1971 a; Lindvall and 
Bjorklund, 1974; Bjorklund et al., 1973). These pathways 
arise from catecholamine containing cell bodies, in the brain 
stem. 
The CA containing perikarya, are described and 
classified, primarily on the basis of topographical and 
morphological criteria. They are classified into twelve 
groups, designated as Al to A12 (Dahlstron and Fuxe, 1964). 
These cell groups are present in the medulla oblongata, 
pons, mesencephalon, caudal thalamus and mediobasal 
hypothalamus (Lindvall and Bjorklund, 1981). Later, one cell 
group in the zona incerta and the caudal hypothalamus, A13, 
(Fuxe et al., 1969) and another in the periventricular gray 
of the anterior hypothalamus and the preoptic region, A14, 
(Bjorklund et al., 1973) were also identified. There are two 
major ascending pathways originating from the NA cell groups 
and supplying the whole of diencephalon and cortex which are 
classified as dorsal noradrenergic bundle (DNA) and ventral 
noradrenergic bundle (VNA). 
Dorsal noradrenergic bundle (DNA) i 
The cell bodies of the DNA arise in the nucleus of 
locus coeruleus. The DNA bundle occupies the dorsal part of 
the ascending group of NA axons. At the caudal level of 
nucleus pontis, these axons turn dorso-medially to form a 
completely separate, dorsal bundle of axons. At the rostral 
level of nucleus mamillaris they turn ventro-laterally to 
join the ascending NE and DA axons which then ascend in the 
medial forebrain bundle and in the septum and then caudally 
into the cingulum. It seems that the pathway radiate 
branches to the corpora geniculata and the thalamic nuclei. 
Lesion studies have shown that this pathway also innervate 
the cortex and the hippocampus. 
Ventral noradrenergic bundle (VNA) j. 
The cell groups which give rise to the VNA bundle 
comprise of Al, A2, A5, and A7 cell groups. These cell 
groups are seen in the medulla oblongata and the pons. The 
axons from these cell bodies ascend in the mid reticular 
formation, turn ventromedially along the medial forebrain 
bundle. This system give rise to NE nerve terminals in the 
lower brain stem, the mesencephalon and diencephalon. In the 
medulla oblongata and the pons, the VNA and the DNA system 
overlap and contribute together to the terminal areas. 
However in the mesencephalon and the diencephalon, the 
majority of NE nerve terminals seem to be derived from the 
ventral system. The VNA bundle innervates the whole of 
hypothalamus and most notably, the nucleus dorso medialis, 
hypothalamus, nucleus periventricularis, the area ventral to 
the fornix, the nucleus paraventricularis, nucleus 
supraopticus and the preoptic area. Further rostrally, the 
ventral pathway supplies the terminals of the densely 
innervated nucleus interstialis stria and terminates in the 
ventral part (Ungerstedt, 1971). 
NEURAL REGULATION OP SLEEP-WAKEFULNE8S; 
Various brain structures are involved in the regulation 
of sleep-wakefulness. These observations have been supported 
by neurophysiological, biochemical and pharmacological 
studies. 
Role of brain stem in sleep-wakefulness i 
To elucidate the role of brain stem in SW, Bremer in 
1937, surgically transected the brain stem of the cat at 
different levels and observed the effects on "brain waves" 
and pupil size. When the transaction was at the level of mid 
brain {cerveau isole' preparation) the EEG consisted of high 
amplitude and low frequency. The pupils were constricted. 
These responses were the same as those recorded from the 
intact sleeping cat. When the transection was at the junction 
of the medulla and spinal cord {encephale isole preparation), 
the EEG consisted of low amplitude and high frequency. The 
10 
pupils were dilated as in the intact awake cat. 
Bremer proposed that most of the sensory input to the 
forebrain was disrupted in the cerveau isole' preparation, 
and the forebrain remained asleep, whereas in the encephale 
isole preparation, sufficient input through the sensory 
nerves maintained arousal and wakefulness. He concluded that 
sleep was a passive process that occurred when the level of 
sensory input fell below a certain predetermined level. In 
1949, Moruzzi and Magoun demonstrated the role of reticular 
activating system of the brain stem. Electrical stimulation 
of the brain stem reticular formation of anesthetized or 
sleeping cats produced desynchronized EEG pattern similar to 
that recorded from an awake animal. Upon lesioning the 
reticular formation, an EEG pattern typical of a sleeping 
animal was observed in addition to somnolence (Morruzi and 
Magoun 1949). 
When the ascending sensory pathways in the brainstem 
were destroyed leaving the reticular formation intact, the 
cats were awake and alert, and a desynchronized EEG pattern 
was recorded. 
In freely moving animals, reticular formation 
stimulation in naturally sleeping or lightly sedated 
animals induced not only EEG arousal but also behavioural 
awakening followed by a whole range of enhanced motor 
activities including the orienting response. In addition. 
11 
ergotropic vegetative reactions such as mydriasis and 
accelerated heart rate were observed. These and other 
findings have led to the establishment of the concept of 
ascending, diffusely projecting reticular activating system. 
Moruzzi and Magoun (1949) on the basis of the above 
observation suggested that cortical arousal and 
wakefulness did not depend on the sensory pathways as 
suggested by Bremer. They said that arousal was produced by 
elimination of the ^waking influence' of the reticular 
activating system, essentially supporting the view that 
sleep is a passive process. According to them the ascending 
reticular activating system lies parallel with, and receives 
collateral input from, the afferent systems. It then tunes 
appropriately the on going excitability level of the cells of 
the cerebral cortex, the basal ganglia, and the forebrain 
structures. They also showed that the arousal effects could 
be produced by stimulation of the region extending upwards 
from the bulbar reticular formation to the mesodiencephalic 
junction (Moruzzi and Magoun, 1949). 
Batini and co-workers (1958, 1959) observed 
desynchronization of the EEG and sustained behavioural 
wakefulness following brain stem transection at the 
midpontine level, just rostral to the trigeminal nerve 
nucleus. These animals showed a marked reduction in the 
occurrence of sleep following brain stem transection. The 
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results were interpreted as evidence for a synchronizing 
structure or sleep-inducing mechanism in the lower brain 
stem. Subsequent experiments, in which electrical 
stimulation of the lower brainstem produced synchronization 
of the EEG and behavioural sleep, localized the region to the 
solitary tract in the medulla (Magnes et al., 1961). High 
frequency stimulation of the region of solitary tract 
produces arousal (Magnes et al., 1961). Low rate stimulation 
of the reticular formation at the mesencephalic level is 
liable to have EEG synchronizing effects, and if applied 
repeatedly, to induce clinical sleep including some of its 
autonomic signs (Favale et al., 1961; Procter et al., 1957). 
Mohan Kumar et al., (1985) have localized the synchronizing 
structures at the nucleus gigantocellularis at the caudal 
brain stem. 
Moruzzi (1972) in his review concludes that the level 
or critical pattern of cerebral activity is controlled by the 
brain stem. A tonic ascending flow of reticular impulses 
would be responsible for the state of wakefulness, its 
complete or almost complete interruption would lead to a 
state of coma, while finally a temporary slackening of the 
tonic reticular discharge might be responsible for the onset 
and the maintenance of natural sleep. 
A high level of reticular activity is defined as the 
one which leads to an organization of encephalic 
activities which mediates an alert behaviour. The level of 
13 
reticular activity was assumed to be higher during 
wakefulness than during sleep because the level of activation 
of the waking brain is higher (Moruzzi 1972). 
The mesencephalic reticular formation neurons tonically 
increase their firing rates during epochs of behavioural 
states associated with EEG activation (wakefulness and 
paradoxical sleep), compared to synchronized sleep. Majority 
of these neurons are found at the ventral levels of the 
reticular core (rostrally projecting neurons are among 
these elements). Movements contribute to further increase 
in discharge rates of the neurons of the mesencephalic 
reticular formation (Steriade et al., 1982). Paramedian 
pontine reticular neurons of cat with head restrained 
at a median rate of 1/sec in the wakeful state, did not 
significantly change in synchronized sleep and reached their 
highest rates in desynchronized sleep. Hobson et al., (1974a) 
and Vertes (1979) reported high levels of discharge in the 
pontine reticular neurons in freely moving rats during 
quiet wakefulness in 16% of the neurons studied. Similar 
results were reported in freely moving cats (Siegel et al., 
1977) showing that pontine neurons reached maximum 
discharge rates of only 2/sec during wakefulness without 
movement. On the contrary, it was shown that 85% of the 
pontine reticular neurons discharged only during movements 
in waking and during rapid eye movements in PS (Siegel et 
al., 1979). 
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The phasic or clustered discharge pattern of pontine 
reticular neurons (McCarley and Hobson, 1975) make it 
improbable that these elements are involved in tonic 
ascending activation process. Rather they seem to be related 
to phasic motor phenomenon during wakefulness and 
desynchronized sleep. In contrast, mesencephalic reticular 
neurons are characterized by tonic discharge patterns 
associated with high discharge rates. 
Medullary reticular cells, like pontine units (Siegel 
and McGinty, 1977; Siegel et al., 1977) discharge in 
relation to specific movements or to maintain postures. 
Their low discharge rates in guiet waking and slow wave 
sleep (SWS) and elevated discharge rates both during active 
waking and PS is also similar to that seen in adjoining 
pontine reticular region (Siegel, 1979) . 
Intracellular recordings of medial pontine reticular 
formation neurons in behaving cats show that excitability of 
these neurons is greater in PS than in waking or 
synchronized sleep. There are phases of depolarization which 
are seen in a background of tonic depolarization. In SWS and 
waking, this background tonic membrane potential is more 
negative than in PS, with phasic depolarizations associated 
with motor activity occurring in wakefulness but not in SWS 
(Ito and McCarley, 1984). 
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Monoaminergic neurons, both locus coeruleus NE neurons 
(Anste'n-Jones and Bloom, 1981) and dorsal raphe 
serotonergic neurons (Trulson and Jacobs, 1979) decrease 
their firing rate from SWS to PS . During waking, discharge 
is regular and tonic, in contrast to discharge patterns seen 
in most medial reticular neurons. During the initial stages 
of SWS, these cells slow slightly. During transition to PS, 
discharge in both serotonergic and noradrenergic cells slows 
dramatically (Sergei, 1989). During PS these cells have 
their lowest discharge rates and many are completely silent 
(Hobson et al., 1975 McGinty and Harper, 1976). 
Dopaminergic neurons (A9 and AlO) showed no change in 
firing rates across the sleep/awake stage in mildly sleep 
deprived rats (Miller et al., 1983). But the non-DA neurons 
of the zona reticular and ventral area of tegmentum exhibit 
large increase in firing rate in PS as compared to SWS and 
active wakefulness as compared to guiet wakefulness. In 
addition to the magnitude of rate change during PS and active 
awake stage, the rapidity of the EMG activity imply an 
important role of these cells in motor function and perhaps, 
in the control of eye movement related phenomenon (Miller et 
al., 1983). Anatomical support for such a role comes from 
the observation that zona reticulata neurons project to 
regions intimately involved in the control of behavioral 
arousal (dorsal reticular formation), locomotion 
(ventromedial thalamus) and usually guided movement (superior 
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colliculus) (Beckstead et al., 1979). 
Significant rise in the frequency of firing of 
mesencephalic neurons before synchronized EEG changes to 
that of awake type is observed. Such precursor signs of 
change is not found in all mesencephalic neurons (Steriade et 
al., 1982). According to them, the existence of such neurons 
suggests that the increased excitability in some 
mesencephalic reticular elements eventually leads to 
recruitment of other neurons in the midbrain core that 
finally play a leading role in the process of EEG 
activation. Such a progressive recruitment might explain, at 
least partially, the long delay between the increase in 
discharge in mesencephalic reticular units and EEG 
desynchronization (Steriade et al.,1982). 
It is thought that cells receiving multiple excitatory 
inputs and rostrally projecting mesencephalic reticular cells 
with high discharge rates are involved in tonic activation 
processes related to EEG desynchronization during 
wakefulness and PS. In addition, rostrally projecting bulbar 
reticular neurons may also be involved in this process 
(Steriade et al., 1982). Paramedian pontine reticular 
neurons are mostly involved in somatic and phasic eye 
movements during PS and during wakefulness (Hobson et al., 
1974b; McCarley and Hobson, 1975; Siegel et al., 1977). 
17 
ROLE OF THALAMUS IN SLEEP-WAKEFULNESS; 
Low rate stimulation of midline thalamus, mainly the 
intralaminar nuclei, in cats and dogs elicits sleep (Hess, 
1944; Akert et al., 1952; Hess et al., 1953; Akimoto et al., 
1956). Thalamic stimulation induced a synchronized EEG 
pattern and behavioural sleep. Sleep-wake cycle was still 
present after complete thalamectomy, although EEG spindles 
were absent during behavioral sleep (Naquet et al., 1956). 
Extensive chronic lesions, in cats, of the midline non-
specific nuclei of the thalamus produced no change in the 
distribution of wakefulness and sleep both with and without 
EEG synchronization. Moruzzi (1972) concluded that sleep can 
be triggered by electrical stimulation of thalamus. In other 
words, electrically induced volleys, arising in the midline 
thalamic nuclei, activate the neural patterns responsible for 
sleep behaviour. In particular, the intralaminar and centre 
median nuclei are thought to be responsible for sleep 
behaviour (Koella, 1984). Low frequency stimulation of these 
areas is an effective means of inducing sleep which outlasts 
the stimulation by 1-2 orders of magnitude, and which induces 
all stages and phases of sleep (Koella, 1984) . On the other 
hand, high frequency stimulation produces a cortical arousal 
pattern similar to the one elicited by classical reticular 
stimulation. It can be concluded that vigilance enhancing 
structures are also present in the reticular region of dorsal 
diencephalon. Thus, lesions in the region of midline 
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thalamus not only to destroy the local hypnogenic networks, 
but also to interrupt parts of the arousal machinery (Koella, 
1984) . 
OTHER BRAIN SUBSTRATES AND SLEEP-WAKEFULNESS; 
High and low frequency stimulation of the basal 
forebrain induces SWS which is followed by PS (Sterman and 
Clemente, 1962b). Lesions produced in these areas resulted 
in a profound suppression of sleep (McGinty and Sterman, 
1968). 
Low rate stimulation of the fornix, of the hippocampal 
region and the region of the solitary tract nucleus induces 
at least isolated signs of sleep (Magnus et al 1961; 
Parmeggiani 1962). 
Cerebellar influences on the SWS mechanisms have been 
indicated after fastigial lesions (Giannazzo et al. , 1969), 
midline cerebellar peduncle lesions and stimulation (Raffaele 
et al., 1971a, b) and after superior cerebellar peduncle and 
cerebellar cortex lesions (Garcia- Uria, 1978; De Andr'e and 
Reinoso-Suarez, 1979; Garcio-Uria et al., 1980). 
Low frequency stimulation of the cerebral cortex 
produces EEG synchronization (Penaloga-Rojas et al., 1964). 
Studies of single cortical neurons in unanesthetized animals 
have shown that during transition from wakefulness to 
drowsiness to SWS, the large majority of cortical neurons 
slow their rate of discharge, whereas large cells as those 
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from which pyramidal tract fibers originate may accelerate 
firing (Hobson and McCarley, 1971) . In the transition from 
SWS sleep to PS, almost all cortical neuron increase their 
discharge rates to levels even higher than those to quiet 
wakefulness (McCarley and Hobson, 1971). 
It is believed that reciprocal interaction exists 
between basal forebrain sleep mechanisms and portions of 
mesencephalic reticular formation and midline thalamus, 
structures involved in the control of arousal. This has been 
concluded on the basis of behavioural studies (Sterman and 
Clemente, 1962a, b) , neurophysiological studies (Bremer, 
1973; Siegel and Wang, 1974) and anatomical studies (Sapawi 
and Diwac, 1978; Swanson, 1976; Swanson et al., 1984). A lot 
of workers have demonstrated monosynaptic projections from 
basal forebrain to neocortex (Irle and Markowitsch, 1984; 
Jones et al., 1976; Mesulam et al., 1983; Wainer et al., 
1984). This suggests a possibility that sleep activating 
neurons directly modulate arousal and cortical excitability 
via actions at the brainstem, thalamus and cortical levels. 
It seems that the basal forebrain is the only site where 
stimulation, lesion and unit recordings yield results 
consistent with the presence of an active hypnogenic 
mechanisms (Szymusiak and McGinty, 1986). 
THE ROLE OF HYPOTHALAMUS IN SLEEP-WAKEFPLNESS; 
von Economo, (1918, 1929) was the first to call 
20 
attention of Physiologists to the involvement of rostral 
hypothalamus in sleep, on the basis of his observations in 
cases of encephalitis. In studying the post-mortem material 
of a strange epidemic termed encephalitis lethargica, he 
described two symptomatic patterns of the disease associated 
with two different localizations of infalmmatory lesions in 
the nervous system. In those cases in which somnolence and 
opthalmoplegy were distinguishing symptoms, the lesions were 
regularly found in the posterior wall of the third ventricle, 
continuing caudally to the level of the occulomotor nucleus. 
In contrast to this, there were other cases in which insomnia 
was observed in addition to chorea. Inflammation in these 
latter patients was associated with the rostral hypothalamus, 
the tuberal region and the adjacent portion of the striatum. 
From these observations, von Economo concluded that the 
rostral hypothalamic zone was a part of a "sleep regulating 
center" which, when appropriately excited, actively inhibited 
the thalamus and cerebral cortex and caused "brain sleep". 
Therefore, he concluded that the rostral hypothalamus is a 
"schlafsteuerungszentrum" or "sleep center". In 1936, Ingram 
reported that in cats a lesion between mamillary bodies and 
the third nerves , which involved the caudal hypothalamus and 
the upper part of the mesencephalic tegmentum, led to a state 
that resembled catalepsy. 
The concept of an active sleep inducing mechanism in 
the central nervous system was finally given a sound 
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experimental basis by Hess (1936), He perfected a method of 
stimulating the brains of unanesthetized, unrestrained cats. 
Using low frequency and low voltage stimulation to several 
forebrain sites, he reported sleep-like behaviour. These 
included the ventral half of the massa intermedia in the 
thalamus, and the lateral anterior hypothalamus, including 
the preoptic and supraoptic hypothalamic areas. The response 
elicited in the latter area was termed "adynamia", since it 
was characterized also by a fall in blood pressure and 
muscular plasticity. 
In 1939, Ranson demonstrated in rhesus monkeys, that 
bilateral lesions in the lateral hypothalamus which extended 
upto the mamillary bodies produced a lethargic syndrome. He 
reported that there was a lack of motor intiative and the 
symptoms were similar to those observed in catalepsy. 
Nauta (1946) provided additional evidence for the 
involvement of hypothalamus in the regulation of sleep-
wakefulness. He made surgical transections across the base 
of the brain at various frontal planes in rats and observed 
the postoperative behaviour of these animals. Transections 
placed in the posterior hypothalamus produced a state of 
persistent somnolence and thus led to the interpretation that 
a waking centre had been separated from the rest of the 
underlying brain. When the transections were made at the 
rostral half of the hypothalamus, particularly at 
suprachiasmatic level then complete insomnia was observed 
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which was uncomplicated by hypothermia. Such a situation 
invariably led to a state of lethal exhaustion. Lateral and 
complete transections, led to sleepless behaviour, which was 
found to be a continuation of relatively normal waking 
pattern. On the basis of the above observations Nauta 
proposed that the rostral» half of the hypothalamus, i.e. the 
area roughly enclosing the suprachiasmatic and the POA was 
responsible for what he called the "capacity of sleeping". 
He further suggested that the sleep cycle was a result of 
periodic decrease in the activity of the waking centre, 
brought about by periodic increase in discharge from the 
sleep centre in the rostral hypothalamus. 
Early stimulation studies performed by Sterman and 
Clemente (1962a, b) on cats have shown that stimulation of 
the area at the base of the rostral hypothalamus resulted in 
an induction of both behaviour and EEG sleep. The behaviour 
elicited by this stimulation involved a series of specific 
events, including cessation of ongoing activity, selection of 
routine location in the cage and assuming normal sleep 
postures. The region effective in eliciting this response 
was anatomically mapped out and was found to include the 
anterior preoptic area and adjacent rostral and lateral basal 
telencephalic tissue. Collectively this area is termed as 
preoptic basal forebrain area (Sterman et al., 1964). Both 
low and high frequency stimulations of this region produce 
the same hypnogenic behavioural and EEG effects. Since 
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differential response to high and low frequency stimulation 
in other areas implied activation of separate neuronal pools 
or frequency sensitive post-synaptic dynamics, this finding 
suggests a relatively homogenous neuronal substrate. 
Collins (1954), French and Magoun (1952), showed in 
monkeys that, large bilateral lesions involving the medial 
and lateral posterior hypothalamic area, produce a profound 
and persistent somnolence. The same findings were confirmed 
in cats (Lindsely et al., 1950; Swett and Hobson, 1968) and 
in the rats (McGinty, 1969; Nauta, 1946; Shoham and 
Teitelbaum, 1982). The lesions cause somnolence accompanied 
by synchronized EEG waves. 
It is believed that the anterior hypothalamus and the 
preoptic regions are the basic neuronal substrates for the 
genesis of SWS and PS and the posterior hypothalamus for 
behavioural wakefulness. 
ROLE OF PREOPTIC AREA IN SLEEP-WAKEFULNESS: 
After von Economo's observations in 1929, several 
studies were carried out to elucidate the role played by the 
PGA in the regulation of sleep wakefulness function. 
Lesion and brain section studies: 
In 1946, Nauta, employing the knife cut lesion 
technique showed that after lesion of the PGA area, the rats 
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became insomniac, restless and irritable. They reacted 
vigorously even to minor stimuli. Those rats which survived 
upto 13 days did not show a return to what he called the 
"capacity of sleeping". He thought that preoptic area was an 
important region for sleeping and he termed this area as 
"sleep centre". Nagel and Satinoff in 1980 reported 
hyperactivity in rats after bilateral electrolytic region of 
the mPOA. Sterman et al., in 1964, confirmed Nauta's 
findings in cats. This was based on behavioral observations 
as well as EEG records. McGinty and Sterman (1968) reported 
that large bilateral preoptic lesions produced complete 
sleeplessness in cats. Smaller lesions resulted in 
significant reduction in SWS as well as PS. The severity of 
sleep suppression was found to be related to the size and 
localization of lesion placed specifically within the POA 
(Lucas and Sterman, 1975). These lesions shortened the mean 
periodicity of the sleep awake cycle with decrease in SWS 
and no alteration in PS (Lucas and Sterman, 1975). Lesions 
produced by neurotoxins such as kainic acid, which spares the 
fibres of passage in the medial and lateral POA, reduce both 
SWS and PS (Szymuisiak et al., 1986; Joshi John et al., 
1994) . 
Electrical, chemical and thermal stimulation of POA 
have also shown involvement of the POA produced changes in 
sleep-wakefulness. 
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Sterman and Clemente (1962b) on the basis of behavioral 
and Electrophysiological observations reported that bilateral 
stimulation of the preoptic region in unanaesthetised freely 
moving cats, produced sleep. Low frequency stimulation was 
effective in inducing sleep. The effect of low frequency 
stimulation (5-25 cycles/sec) on induction of sleep was 
confirmed by Hernandez - Peon (1962), Chavez - Ibara (1962) 
and Yamaguchi et al., (1963). These studies were also 
carried out in conscious cats. In addition they showed that 
high frequency stimulation (200-300 cycles/sec) induced 
cortical EEG desynchronization and some signs indicative of 
behavioral arousal. Thus, it can be concluded that both 
sleep and arousal responses can be obtained from electrical 
stimulation of preoptic area, depending upon the rate and 
site of stimulation. 
Warming the preoptic area produces sleep (Von Euler, 
1964; Roberts and Robinson, 1969; Parmeggiani et al., 1974; 
Benedek et al., 1976). Sleep could be induced by radio 
frequency diathermic warming of preoptic area in cats and 
opossum (Roberts and Robinson, 1969). Cooling the preoptic 
area produces huddled posture (Freeman and David, 1959) . 
Roberts and Robinson (1969) have suggested that 
preoptic thermoreceptors may provide input to preoptic sleep 
mechanisms. Stimulation of central receptors by changing 
blood temperature is likely to be an important source of 
impulses driving the sleep inducing structures of basal 
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forebrain (Morruzi, 1972). 
Cell specific neurotoxic lesion studies counter the 
argument that the effects produced by other means also 
destroy the fibres of passage. Asala et al., in 1990, 
reported decrease in day time SWS in rats as a result of 
radio frequency lesion of mPOA. This also disturbed the 
circadian distribution of sleep. 
In 1965, Hernandez-Peon showed that application of ACh 
at the POA elicited EEC synchronization and sleep, whereas 
application of NE at same site elicited EEC 
desynchronization and arousal in cats. The induction of 
arousal after application of NE crystals in the preoptic 
area was confirmed in cats by Yamaguchi et al., (1963). 
Garcio-Arraras and Pappenhermer (1983) demonstrated that 
microinjection of sleep promoting muramyl peptide in the same 
area promotes sleep. Application of 5-HT crystals in the POA 
produced drowsiness and SWS in freely moving rats Yamaguchi 
et al., (1963) but Datta et al., (1987) showed that 5-HT 
application at the same site did not have ciny change in SW. 
Mallick et al., (1983) showed that a majority (55%) of 
neurons of POA showed alterations in their firing rate during 
transient changes in EEC. Among these 62.5% showed increased 
firing during synchronization and the remaining 37.5% showed 
increased firing during desynchronization of the EEC. 
Findlay and Hayward (1969) showed that majority of the 
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neurons in the hypothalamus, including preoptic region showed 
an increase in their firing rates during sleep than awake in 
freely moving rabbits. In cats, maximal discharge rate was 
obtained during SWS and REM sleep (Kaitin, 1981, 1984). A 
small percentage of neurons (10%) showed a maximal discharge 
rate during awake period. These observations thus support the 
earlier stimulation and lesion studies that POA is involved 
in both sleep and wakefulness functions. 
THE ROLE OF CATECHOLAMINES IN SLEEP-WAKEFULNESS: 
In 1958, Scheving et al., showed that the concentration 
of endogenous NE in the different regions of the rat brain 
varies with different time of the day. Such an observation 
was also supported by observations in the cat brain (Reis et 
al., 1968). Using labeled tyrosine, Zigmond and Wurtman 
(1970) showed in rats that newly synthesized catecholamine 
pool is larger during the day than in night. 
Manipulation of the Catecholaminer-gic system has been 
accomplished by a Vciriety of methods to study its effects on 
SW. 
1. Oral or systemic administration of catecholamines. 
2. Destruction of catecholaminergic system. 
3. Intraventricular administration of catecholamines. 
4. Local intracerebral injection of catecholamines. 
1. Oral and systemic injection studies 
Early pharmacological studies to elucidate the role of 
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CA in S-W were made by systemic injections of various 
drugs. Moderate doses of NE and adrenaline injected in cats 
produced arousal which was accompanied by an increase in 
peripheral sympathetic tone and blood pressure (Bonvallet, 
1954; Dell, 1960). This activating effect of NE was 
abolished by transection or lesion of the mesencephalic 
reticular formation. On the basis of these observations, it 
was considered possible that the neurons of the reticular 
activating system were adrenergic. However Dell (1960, 1963) 
reported that adrenaline and NE do not cross the blood brain 
barrier in any significant amount except in the hypothalamus 
and a few places in the brain stem in the adult animals 
(Weill-Mall-Herbe, 1959). 
In chicken (not older than 28 days) , whose blood 
brain barrier is permeable to CA, intravenous injection of 
adrenaline, NE and isoprenaline induced behavioral and 
electrocortical sleep, whereas NE injected directly into the 
brain, showed signs of behavioral sedation without 
electrocortical synchronization (Marley and Key, 1963; 
Spooner and Winters, 1966; Marley and Stephenson, 1970). On 
the contrary, in adult chickens, the same drugs given 
intravenously elicited arousal (Dewhurst and Marley, 1965). 
However, the above mentioned drugs caused hypertension 
in both young and older birds. This could produce excitation 
of baroreceptors in the sino-aortic region which could have 
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produced the synchronization of EEC. Bonvallet e t a l . , in 
1953 showed tha t exci tat ion of baroreceptors produced by 
increasing pressure in s ino-aort ic region, produced a cen t ra l 
s h i f t towards synchronizat ion of the EEC. Marley (1966) 
showed tha t CA which were injected intravenously were not 
taken up se lec t ive ly by the central NE terminals . 
Intravenous injection of methoxamine (alpha 1- agonist) 
caused a s i g n i f i c a n t and dose r e l a t e d dec rease in t o t a l 
s leep , which was antagonised by phenoxybenzamine (Pickworth 
e t a l . , 1977). In r a t s , orally administered clonidine (alpha 
-2 agonist) reduced waking time and increased l i gh t sleep 
with s p i n d l e a c t i v i t y (Kleinlogel e t a l . , 1975). 
In t r avenous i n j e c t i o n of the same drug in r a t s , caused 
cur l ing up and in acquisit ion of sleeping posture, but the 
eyes remained open. Short EEG samples revealed synchronized 
pa t t e rns with high voltage slow wave a c t i v i t y , (Holman et 
a l . , 1971, Floro e t a l . , 1975). Alpha-Methy1-P-Tyrosine 
(alpha-MPT) decreases cerebral CA by inh ib i t ing the r a t e 
l i m i t i n g enzyme t y r o s i n e hydroxylase in the b i o s y n t h e t i c 
pathway of CA (Anden et a l . , 1966). Due to t h i s reason i t i s 
not t o l e r a t ed well in chronic experiments. Systemic in jec t ion 
of MPT produced behavioral and EEG s leep. Such experiments 
were car r ied out in r a t s (Marantz and Rechleschaffev, 1967; 
Torda, 1968; Branchey and Kissin, 1970), in monkey (Weitzman 
e t a l . , 1969) in rabbi ts (Fujimori et a l . , 1971) and in 
ca t s (Iskander and Kaelbling, 1970; King and Jewett , 1971) . 
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The common effect observed in all the species after injection 
of alpha - MPT was a decrease in behavioral and EEG 
activity. A state of sedation induced by alpha- MPT could be 
reversed by a subsequent injection of L-DOPA (Weissman and 
Koe, 1965; Rech et al., 1966; Fuxe and Hanson, 1967; Hanson, 
1967; Schoenfeld and Seiden, 1969). Such a reversal by L-
DOPA indicated that the effects produced by alpha- MPT were 
due to inhibition of tyrosine hydroxylase which resulted in a 
decrease in NE and DA. 
Tremorine, which enhances tyrosine hydroxylase activity 
did not produce significant variation in SW (Ramm and Taub, 
1980). In laboratory animals and in humans, administration of 
amphetamine, which increases the concentration of NE and DA 
at the post synaptic site, shifts the balance towards 
increased wakefulness (Backeland, 1967; Gillin et al., 1975; 
Hartmann and Cravens, 1976). 
Disulfiram (an inhibitor of dopamine B-hydroxylase), 
reduces NE content and increases DA stores (Carlsson et al., 
1966; Goldstein and Nakajima, 1967; Lippman and Llyod, 1969). 
In cats, disulfiram reduces both waking and PS period (Dusan-
Peyrethan and Froment, 1968). 
In mice and rats, disulfiram has a sedative effect on 
behaviour (Moore, 1969; Roll, 1970). Inhibitors of monoamine 
oxidase (nialamide) increases CA concentration and are 
associated with the accumulation of NE and an almost 
31 
permanent arousal in rabbits and rats. (Costa et al., 1960; 
Mouret et al., 1968). If DOPA is injected together with MAO, 
which produces a further increase in CA, it induces an 
intense excitement with long lasting cortical activation in 
cats (Jones et al., 1970) and also in rabbits (Monnier and 
Graber, 1963). 
Destruction of Catecholaminerqic system: 
Jones et al., (1973) reported that electrolytic lesions 
of DNA and the anterior extension of the pontine NE group A6 
(anterior nucleus of locus coeruleus) produced a significant 
decrease in electro-cortical waking. If the nebular complex 
and mesencephalon (both of which are correlated with NE were 
lesioned, decreased waking was observed. This decrease in 
waking was more severe as compared to that produced by DNA 
lesion. Jones et al., (1973) suggested that waking may be 
tonically mediated by a highly diffused NE system which 
consists of several groups of NE cell bodies in the pons and 
medulla which send projections throughout the brain. Such a 
system would permit the control of entire brain by a few 
cells which are localized in the brain stem. These cells 
would be subjected to the control by sensory and other inputs 
and that could in turn control the entire brain by their 
diffuse projections. These characteristics might fit well in 
the concept of a diffuse activating system. 
In rats, lesions of DNA by 6-OHDA, resulted in a 
decrease in wakefulness with an increase in SWS. An 
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increase in quiet wakefulness was observed in VNA lesioned 
rats with 6-OHDA (Mohan Kumar et al., 1993). PS is not 
altered significantly (Lindbrink and Fuxe, 1973). Lidbrink 
(1973) has also reported that an acute transient decrease in 
EEG wakefulness and increase in SWS after DNA lesions. In yet 
another study in 1974, Lindbrink showed that after DNA lesion 
the electrocortical activity during behavioral wakefulness 
(quiet wakefulness) consisted of synchronized slow waves to a 
much greater extent than was found in intact animals. 
Panksepp et al., (1973) reported the effects of 6-OHDA 
induced VNA lesions in cats. The acute effects were a shift 
towards electrocortical arousal, although the long terra 
changes were just the reverse. Deep SWS and REM sleep were 
increased while a decrease in quiet waking and SWS were 
observed. However the authors did not rule out widespread 
damage to DNA. 
Intraventricular administration of catecholamines: 
Bukkard et al., (1969) injected 6-OHDA in the 
ventricles in rats. No change in SW or the behaviour of the 
animal was reported. Laguzzi et al., (1972) reported 
increased synchronization and decrease in PS after a similar 
operation in cats. This kind of study is unsuitable due to 
the lack of anatomical dimensions of the lesions. 
Direct intraventricular injection of NE in cats 
produces a state of prolonged wakefulness, most often 
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accompanied by increased motor activity (Cordeau et al., 
1971) . Intraventricular infusion of NE in unrestrained rats 
also leads to an increase in behavioural arousal and 
spontaneous motor activity (Segal and Mandell, 1970; Geyer et 
al., 1972; Smee et al., 1975). 
Intraventricular infusion of methoxamine in rats 
provoked a persistent and dose related behavioural arousal, 
comparable to that elicited by NE (Segal and Geyer, 1976) but 
prazosin, an alpha-1 antagonist, which binds specifically to 
alpha-1 adrenoceptors in rat brain (Miach et al., 1980) 
moderately decreased waking, although NREM sleep was not 
altered (Hilakivi et al., 1980). 
Clonidine produced curling up and sleeping posture in 
rats, but their eyes remained open. Short EEG samples 
revealed synchronized pattern with high voltage slow wave 
activity (Holman et al., 1971; Florio et al., 1975). Sedation 
and decreased motor activity similar to that caused by 
clonidine also occurred in freely moving rats following 
intraventricular injection of Xylazine and naphazoline. These 
effects were antagonized by Phentolamine and Yohimbine (Drew 
et al., 1979). 
The results of intraventricular studies are very 
difficult to interpret, as minute amounts of labeled CA 
have shown to have be taken up by non-CA neurons 
(Lichtensteiger and Lageman, 1966; Fuxe and Ungerstedt, 1968; 
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Fuxe et al., 1968). Thus, it is likely that in some cases NE 
might have induced some response upon non-CA neurons. 
Local intracerebral injection of catecholamines; 
Bilateral infusion of NE, epinephrine or phenyleprine 
into the pontine and mesencephalic reticular formation of 
cat, in encaphale isole preparation produced electrocortical 
desynchronization and behavioural arousal. When high 
concentration of these substances were used, the tonic 
electrocortical desynchronization was replaced by a pattern 
of slow wave activity (Key, 1975). 
Injection of NE (3ug) at the medial preoptic area 
produced arousal in sleeping rats which lasted for more than 
60 min (Mohan Kumar et al., 1984, 1986). This arousal 
resembled normal arousal. 
Blockade of adrenergic receptors by phentolamine and 
phenoxybenzamine (which blocks both alpha- 1 and alpha- 2 
receptors) did not result in significant changes in waking 
time, although the animals appeared behaviorally sedated 
(Putkonen and Leppavuori, 1977; Hartman and Zwilling, 1976). 
Injection of alpha blocker, phenoxybenzamine, at mPOA 
produced sleep in awake animals whereas propranolol was 
ineffective (Mohan Kumar et al., 1984, 1986). 
In cats administration of clonidine and xylazine 
decreased deep NREM sleep and increased light sleep and 
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drowsiness (Putkonen et al., 1977; Putkonan, 1979; Leppauuori 
and Putkonen, 1989), In rats, clonidine was reported to have 
induced sleep, whereas yohimbine (alpha-2 antagonist) induced 
arousal (Mallick and Alam 1992). Injection of methoxamine 
which is an alpha-1 agonist induced arousal whereas as 
prazosin (alpha-1 antagonist) induced sleep when administered 
at the mPOA, Alpha-methyl-NE also depresses NE transmission 
by a direct stimulatory action on alpha-2 adrenoceptor. 
Alpha-methyl-dopa which is metabolized to alpha-methyl NE, 
markedly decreases REM sleep and increases NREM sleep in 
kittens at birth (Saucier and Astic, 1975). In cats, it 
augments light sleep at the cost of arousal (Leppvuori and 
Putkonen, 1978, 1980). 
In addition to alpha receptors, beta receptors are also 
thought to be involved in the regulation of sleep-wakeful 
function. Beta adrenoceptor blocker propranolol and ICI 
118551 when administered peripherally produce an increase in 
SWS (Dehlinger et al., 1981; Reiner et al., 1986 and 
reduction in PS (Remer et al., 1986; Ongini et al., 1991). 
Carbachol, a cholinergic agonist, when applied at the 
mPOA, produced a fall in rectal temperature and induced an 
injection bound long lasting arousal (Talwar et al., 1994). 
Administration of GABA at the mPOA did not produce any 
significant alteration in SW (Chari et al., 1995). 
Injection of propranolol into the mPOA in rats did not 
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produce any change in the SW (Datta et al., 1988; Mallick and 
Alam, 1992). On the other hand beta agonist isoproterenol 
induced wakefulness for about 90 min, whereas both 
isoproterenol and propranolol could produce only wakefulness 
of 30 min. These results are suggestive of involvement of 
beta receptor in regulation of sleep wakefulness. However 
reports to the contrary are available. Application of NE into 
the mPOA after destruction of presynaptic receptors produced 
sleep whereas in normal rats produced wakefulness (Mohan 
Kumar et al., 1993). As presynaptic fibres are destroyed in 
the mPOA the sleep produced could be due to the activation of 
postsynaptic receptors by externally applied NE. Therefore it 
is suggested that the arousal produced by NE application in 
the mPOA is due to its action on auto receptors therby 
inhibiting the release of endogenous NE. 
The overview of the preoptic area clearly suggests that 
the mPOA plays a role in the mediation of sleep-wakefulness. 
CHAPTER 3 
LACUNAE AND AIMS 
LACUNAE AND AIMS 
From the above literature it is evident that the exact 
target site for the action of externally applied NE needs 
further clarification. It also points out the need for 
further study into the role of noradrenergic autoreceptors in 
the regulation of sleep-wakefulness. Hence the main aim of 
this study was to study the role of alpha-2 adrenoceptors in 
the regulation of sleep-wakefulness at the level of medial 
preoptic area (mPOA). 
CHAPTER 4 
MATERIALS AND METHODS 
MATERIALS AND METHODS 
The approach to the study was made as follows: 
intracerebral microinjection of alpha-2 agonist and 
antagonist administered slowly into the mPOA. The drugs used 
were clonidine -an alpha-2 agonist and yohimbine -an alpha-2 
antagonist. This approach clearly elucidates the action of 
endogenously released NE at the postsynaptic membrane in S-W 
function (details regarding mechanism will be dealt 
separately in the discussion chapter). 
Experiments were carried out on free-moving male Wistar 
rats, weighing between 225-275 gms. These rats were implanted 
with EEG, EMG and EOG electrodes soldered over to an IC 
sockets which were then fixed on to the skull with dental 
cement. A bilateral guide cannula was stereotaxically lowered 
through a small hole on the skull. It was then fixed on the 
skull in such a way that its lower tip was 2mm above the 
mPOA. Various drugs were injected through an "injector 
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cannula", whose tip would reach the mPOA when introduced 
through the guide cannula. All animals were finally 
sacrificed and the brains were processed for histological 
verification of the cannula placement and drtig injection. 
Further details of materials, instruments, methods, histology 
and analysis of data will be described under the following 
headings and sub-headings. 
MATERIALS AND INSTRUMENTS: 
(a) Animals 
(b) Cannula Assembly 
(i) Guide cannula 
(ii) Stylette 
(iii) Injector cannula 
(c) Electrodes 
(i) EEG 
(i i) EMC 
(iii) BOG 
(iv) Ground 
(d) Anaesthetics / drugs / chemicals 
(e) Stereotaxic instruments 
(f) Experimental recording cage 
(g) Polygraph 
(h) Slow-injector 
(i) Suction pump 
(j) Microtome 
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METHODS: 
(a) Selection of animals for experiment after surgical 
procedure 
(b) Stereotaxic implantation of bilateral guide cannula and 
electrodes 
(c) Post operative care 
(d) Electrophysiological recording 
(e) Method of intracerebral microinjection 
(f) Protocol 
HISTOLOGY: 
(a) Procedure for sacrificing the animals 
(b) Histological methods employed to verify injection site 
ANALYSIS OF DATA: 
(a) Scoring and analysis of S-W data 
(b) Statistical analysis 
MATERIALS AND INSTRUMENTS; 
(a) Animals 
Male Wistar rats weighing between 225-275 gms, bred and 
reared in the Experimental Animal Facility of All India 
Institute of Medical Sciences, New Delhi were used in this 
study. They were labeled and housed in separate polyethylene 
cages (35 x 24 x 14.5 cms), with paddy husk for warmth, in 
the Departmental animal house, having controlled room 
temperature (26 ± 1°C) and 14 hr light (5.00 hrs - 19.00 hrs) 
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and 10 hr dark schedule. They were provided with rat food 
(Lab Chow, Hindustan Lever, India), soaked grains and water ad 
libitum. The husk bedding was changed every day. 
Justification for the choice of animal species: 
Rats were chosen for this study for the following reasons: 
1. Easy availability and low-cost maintenance. 
2. Easy to handle during chronic recordings, which requires 
free-moving animal model. 
3. As it is less distracted by surrounding disturbances, it 
is the most suitable animal for short-term/long-term sleep 
studies. 
4. Suitable for electrophysiological and intracerebral 
microinjection studies. 
5. Relevant literature on S-W pattern is available. 
6. Many milestone findings on the involvement of the POA in S-W 
and thermoregulation were reported on the basis of studies 
on this species. 
7. The neuronal pathways and its neurotransmitter profile has 
already been extensively studied in this species. 
8. The mPOA is better demarcated and more prominent in rats. 
9. Easily adapted to the laboratory environment. 
(b) Cannula Assembly 
The cannula assembly for microinjection of the drugs 
consisted of a bilateral guide cannula, stylettes and an 
injector cannula attached to a microlitre syringe through a 
polyethylene tubing (Fig 4.1). 
Fig. 4.1 : The figure shows the cannula assembly for 
intracerebral microinjection in conscious 
animals 
Fig. 4.2 : (E) Shows the photograph of the guide 
cannula. Note the left cannula has an 
indwelling injector cannula of which, the tip 
protrudes 2mm below the guide cannula 
Fig. 4.3 : (C) Shows the photograph of a stylette 
Fig. 4.4 : (D) Shows the photograph of an injector 
cannula 
Fig. 4.5 : (A) Shows the photograph of a screw electrode 
used for recording EEG and also used as a 
ground electrode 
Fig. 4.6 : (B) Shows the photograph of a loop electrode 
used for recording EMG and EOG 
Fig. 4.9 : (F) Shows the photograph of a bilateral guide 
cannula with indwelling stylettes prior to 
Implantation 
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(i) Guide cannula: The bilateral guide cannula were 
constructed from 26 G stainless steel tubing. Such tubings 
were cut and ground on a Carborundum combination stone to get 
the required length of 15mm with a smooth edge. Two such 
cannulae were attached to each other by soldering them with a 
bridge in such a way to form a "H" shaped assembly. The 
cannula were separated by a distance of 1.2 - 1.4mm (Fig 
4.2) . 
(ii) Stylette: Stainless Steel wire of 34 G was pulled and 
cut to the desired length. Small pieces, approximately 4mm, 
of polyethylene tubings were cut and passed over the 
stainless steel wire. One end of the wire was bent so as to 
form a hook. The cut tubing was fixed at this end. Araldite 
v/as applied to fix the tube to the stainless steel wire. The 
length of the wire was adjusted in such a way that it 
completely filled the base of the guide cannula when it was 
introduced inside (Fig 4.3). 
(iii) Injector cannula: Injector cannula was constructed from 
32 G stainless steel tubing. After the desired length of the 
tubing was carefully cut, taking care that its patency 
remained intact, a small length of the tubing (approx. 2mm) 
was inserted into 24 G stainless steel tubing (which acted as 
a stopper) and firmly soldered at the junction. Then the 
length of the injection cannula was kept in such a way that 
it protruded exactly 2mm beyond the guide cannula when 
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inser ted into i t (Fig 4 .4) . 
(c) Electrodes; 
(i) EEG electrodes: Stainless steel screw electrodes were 
used for recording EEG. These consisted of 2mm long and 
slender screws soldered on the top to a light weight, 
flexible radio wires (Fig 4.5). 
(ii) EMG electrodes: 40 G stainless steel wire was cut 
approximately 5mm and twisted to form a loop. These were then 
carefully soldered on to light weight, flexible radio wires. 
The neck of the loops were insulated with insulex (Fig 4.6). 
(iii) EOG electrodes: These were prepared in the same manner 
as that of EMG electrodes. 
(iv) Ground electrode: These were prepared in the same manner 
as that of EEG electrodes. 
(d) Anaesthetics / Drugs / chemicals; 
Pentabarbitone sodium, (C.j^ j^ Hj^ N^2Na03) , (Aldrich Thomas 
Co., USA) was used as anaesthetic. 
Drugs used for intracerebral microinjection were 
yohimbine hydrochloride (Sigma Chemical Co. , USA) and 
clonidine hydrochloride (Sigma Chemical Co., USA). Dimethyl 
sulfoxide (Sigma Chemical Co., USA) and sodium chloride (BDH 
Laboratory Chemical Division, Glaxo Laboratories (India) 
Ltd.) were used as respective vehicles. 
For aseptic precaution and post operative care, 
Betadine (Win-Medicare, India) and Nebasulf (Pfizer Ltd., 
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India) were used. 
Chemicals used for perfusion and staining for 
histological verifications were ferric chloride, (FeCl^) , 
(BDH Laboratory Chemical Division, Glaxo Laboratories (India) 
Ltd.), potassium ferrocyanide, (K^(Fe(CN)g).3H2O), (SD Fine 
Chem Ltd., India), Eosin (Merk, Germany) and Hematoxilin 
monohydrate (Merk, Germany). 
For control injections, dissolving drugs and preparing 
vehicles, sterile and pyrogen free 0.9% (w/v) saline was 
used. This was prepared using sodium chloride (BDH Laboratory 
Chemical Division, Glaxo Laboratories (India) Ltd.) dissolved 
in double distilled water. 
(e) Stereotaxic Instriiments: 
Stereotaxic instrument of David Kopf instruments was 
used for all stereotaxic surgical procedures, viz., lowering 
of the guide cannula into the mPOA, It has a "[" shaped frame 
which is fixed on a long stainless steel rod which is 
ultimately fixed on to the operating table. The arms of the 
"[" are extended to form the calibrated lateral bars. Clamps 
in the lateral bars permit the calibrated aural bars to be 
fixed at right angles but in the same horizontal plane, k 
detachable rat head holder consisting of incisor bar and nose 
clamp with a longitudinal groove can be mounted at the center 
of the body of "[" frame. Longitudinal grove in the head 
holder permits its movement in the rostro-caudal direction. 
Fig. 4.7 : Shows the photograph of a polygraph used for 
polysomnographic recording 
Fig. 4.8 : An animal in the stereotaxic apparatus with 
implanted electrodes, prior to implantation 
of guide cannula 
^^^^^k 'k H ^^ 1 i 1 i j 1 
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The incisor bar has calibrations and can be moved vertically 
so that the head could be fixed according to any atlas above 
or below the intra aural line. The nose clamp helps to keep 
the head of the animal pressed down firmly. 
The electrode carrier was a "L" shaped strip fixed with 
a crocodile clip to one end. This was fabricated to fit on 
the lateral bars of the "[" shaped frame with the help of a 
slidincj clamp. This was a "T" shaped calibrated assembly 
which had provision to enable the guide cannula fixed on to 
the carrier to move rostro-caudal, medio-lateral or dorso-
ventral by rotation of respective knobs. There were screws, 
which when tightened prevented accidental movement of the 
arms. 
(f) Experimental recording cage; 
It was a rectangular wooden box (45 x 30 x 32 cms) , 
provided with a glass on one side to enable to view the 
animal behaviour. On top of the box was a small opening to 
fix the swivel, through which recording wires could be taJcen 
out. Through the viewing glass various behaviour of the 
animal could be observed. This errtire set up was placed in a 
Faraday's cage to prevent any interference from 50 cycle 
power lines. 
(q) Polygraph; 
A 8 channel polygraph, model 7B of Grass Instruments 
Co., Quincy, Mass., USA, was used in this study (Fig 4.7). 
46 
It could record both AC and DC input signals. Details of the 
accessories which was used in the present studies are 
described below. 
Electrode board (Model EB24): The picked up signal was fed to 
an electrode board which had 24 active position (1-24) jack 
and a ground jack labeled GND. Electrode connector pins were 
plugged into the active jacks, and the ground pin to the 
ground jack. 
Electrode selector panel (Model 7ES P24): The electrode board 
was connected to the electrode selector panel which had two, 
Gl and G2 selector indicator rotary switch corresponding to 
each channel, which enabled to select the positions between 
1-24 of the electrode board for selective recording. In the 
selector panel, there was one selector switch which could be 
turned to either "cal" or "use" position. The required 
calibration signals were selected by turning a rotary 
switches. The voltages of calibration signal provided in the 
panel were 5, 10, 20, 50, 100, 200 uv and 0.5, 1, 2, 5, 10, 
20 mv. The calibration signal usually used for EEG, EMG and 
EOG were 100 uv. 
Main frame: The main frame of the polygraph had 8 channels. 
Each of the channels consisted of one wide band AC 
preamiplif ier, one DC driver amplifier and one pen writing 
system. The main frame had a master switch to regulate the 
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power into the system. 
The polygraph also had a separate channel as timer 
which gave pulses at every second. The pulses after every 
5th second was bigger than the previous pulses and the pulses 
were still bigger after every 60th second. The same channel 
could also be used as a stimulus marker which • could be 
manually driven. The stimulus marker gave upward/downward 
deflection depending on the selector. Moreover the mark could 
be given with a remote control or with the help of a switch 
on the body of the polygraph. 
Wide band AC preamplifier (Model 7P5B): It consisted of a 
male socket, which received the female lead from the 
electrode selector panel, of the respective channel. There 
was a pair of selector Gl and G2 which were kept at 2 and 3 
for recordings. Amplification could be set to different 
sensitive settings (20, 30, 50, 75, 100 and 150 uv/cm) and a 
three step multiplier knob (xl, xlO and xlOO) helped to 
amplify the signals further. Apart from this, there was a 
continuous variable knob which could be adjusted to get the 
amplification in between each of the two st-eps of the 
amplification. The preamplifier provided a 5 step 1/2 
amplitude low frequency cut-off knob at 5 different frequency 
limits of 0.15, 0.3, 1, 3 and 10 Hz, having corresponding 
time constants of 0.45, 0.24, 0.1, 0.04 and 0.015 sec 
respectively. The high frequency cut off was provided in the 
DC driver amplifier. 
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DC driver amplifier (Model 7DAEF); All eight channels 
consisted of this type of driver amplifier. Its function was 
to amplify the power of the signal, so that the pen could be 
moved. There was a push button cal knob where the adjusted 
calibration rest at -100 mv. Usually it was kept at 2 cms pen 
deflection. The high frequency cut-off provided frequency 
ranges at 0.1, 0.5, 3, 15, 35 Hz, 75 Hz-40 KHz, 75 Hz-3 KHz 
end 75 Hz-0.5 KHz. It had an additional 50 Hz filter switch, 
which selectively filtered the 50 cycle line frequency. Each 
individual channel could be kept "off/stand by/ on" mode by 
proper selection of ^push-turn' switch. The polarity switch 
selected the movement of the pen upward or downward to that 
of the base line. The base line adjustable knob enabled the 
positioning of bring the pen in a horizontal line. For 
recording the signal, coming from the preamplifier, the 
calibration switch "use/cal" was kept at "use" position. 
Chart drive (Model H25-50): The paper speed was selected by 
pressing the respective push but^ ton switch, which regulates 
the paper at 12 different speeds, 2.5, 5, 10, 25, 50 and 100 
mm/sec or mm/min. The paper speed set for this s-tudy was 10 
mm/sec. 
(h) Slow injector: 
The slow injector of C.F.Palmer, London had one syringe 
rack which fixed the syringe tightly. It also had a piston 
which could move the piston of the syringe forward at varying 
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speed. The rate of microinjection could be selected by 
varying the speed of movement of the piston. The gears in the 
slow injector permitted the speed of movement of the piston 
at 10, 20, 40, 80, 160 and 320 min/inch. In the present study 
the piston was set at the speed of 20 min/inch. 
(i) Suction pvunp: 
The suction pump of Widsons Scientific Works, India, 
was used to remove the tracheal secretions of the animal as 
and when required. 
(j) Microtome: 
A rotary microtome (Ernst Leitz, Germany Wetzlar) was 
used to cut sections from the paraffin embedded tissue 
blocks. 
METHODS 
(a) Selection of animals for experiment after surgical 
procedure; 
Healthy normal Wistar male rats, weighing between 225-
275 gms, were selected. Those rats which had regular pattern 
of food and water intaike were taken. Rats with middle ear 
infection, abnormally high body temperature, or lethargic 
were not used for the study. 
(b) Stereotzucic implantation of bilateral cfuide cannulae and 
electrodes; 
The surgery was carried out asceptically in a 
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stexilized environment. All surgical instruments and guide 
cannula were sterilized. The animal was then weighed and 40 
mg/kg b.w. of anaesthesia (pentabarbitone sodium) was 
administered intra-peritoneally. After the animal went into 
anaesthesia, the head was shaved and Savlon was applied to 
the skin over lying the head. The animal was then fixed onto 
the stereotaxic instrument. The respiration was monitored 
throughout the experiment visually. In case of respiratory 
distress, the animal was removed and necessary resuscitation 
was followed until the respiration came back to normal. The 
incisor bar was set 5 mm above the intra aural line (lAL) in 
accordance with De Groots atlas ( De Groot, 1959) . 1 ml of 
xylocaine (as local anaesthetic), was injected under the skin 
of the head. A longitudinal midline incision was made with a 
new, sterilized scalpel blade from behind the eyes upto 
around 1 cm caudally. The periosteal muscle was retracted 
with a blunt spatula, to expose a small portion of the 
frontal bone, the bregma, the coronal sutures, the sagittal 
suture, the lambda and a small portion of the occipital bone. 
The skin was retracted and around 1.5 mm of the skin was cut 
on both sides. The surface of the skull was wiped dry with 
co1:ton wool to visualize the sutures clearly. 
Two tiny holes were drilled, with the help of a watch-
makers screw driver for placing bilateral screw electrodes 
(Fig 4.5) onto the skull, 2 mm rostral to the bregma and 4 mm 
lateral to the mid sagittal suture, for recording EEC. A 
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unilateral screw electrode was placed similarly approximately 
5 mm away from the EEG electrodes, rostrally at the naso-
frontal portion of the skull. The EMG electrodes (Fig 4.6) 
were placed bilaterally into the dorsal nuchal muscle and 
sutured with a sterilized silk suturing thread. Similarly two 
EOG electrodes were sutured to the external canthus region 
of the eye on either side. 
Three separate holes were drilled, one lateral to the 
ground electrode (on the contralateral side) and two others 
caudal to the lambda placed laterally on the either sides to 
fix the anchoring screws. (Anchoring screws are used to 
anchor the self-curing acrylic cement to the skull along with 
the electrodes and cannula in place). A film of self-curing 
acrylic cement was applied on the sides to fix the recording 
electrodes. 
Two tiny holes were drilled 0.6 mm lateral to the mid 
sagittal suture, and a bilateral guide cannulae for the 
injection of drugs at the mPOA was lowered by means of a 
holder, 2 mm above the mPOA at coordinates A 7.8, H 0.5 and L 
0.6 mm as per De Groots atlas (Fig 4.8). The bilateral guide 
cannula was plugged with stylettes, prior to implantation, to 
keep it patent (Fig 4.9). Self-curing acrylic cement was 
poured around the guide cannulae. After curing of the 
cement, the holder was sepiarated and removed from the 
cannulae. 
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All distal ends of the recording electrodes were 
trimmed and soldered on to an eight legged IC socket, which 
was then fixed on the skull. 
(c)' Post operative care; 
After the surgery the animal was gently taken out of 
the stereotaxic instrument. Nebasulf sprinkling powder, 
containing neomycin sulphate, bacitracin and sulphacetamide 
was sprinkled around the dental cement. Betadine was also 
applied. The animal was then gently placed in the cage on a 
filter paper sheet and warmth provided by an incandescent 
light. The cage was half-covered on the top, so that the 
animal could prefer either side of the cage. The animal was 
constantly monitored till about 30 rain after it came out of 
anaesthesia. For the next 4-5 days, the animal was 
periodically monitored. Food and water were provided ad 
libitum. Recovery from the post operative trauma was assessed 
by the observation of body temperature, food-water intake and 
general behaviour of the animal (4.10). The animal was then 
fcimiliarized with the recording cage prior to the experiment. 
(d) Electrophysiological recording; 
After the- animal was acclimatized to the recording cage 
for a minimum of 30 min the preinjection recording of EEG, 
EMG and EOG was started. The lead wires from the male socket 
(which were plugged on to the rats's head) were connected to 
the electrode board, which is in turn was connected to the 
electrode selection panel. The electrode panel switch sends 
53 
the signal to the preferred channel via wide band AC 
preamplifier and DC driver amplifier. The settings of the 
amplifiers for the recording of EEG, EMG and EOG were as 
shown in the Table 4.1. 
The recording was carried on continuously for 90 min. 
Then 0.2 ul of the drug in question was administered at a 
flow rate of O.lul/min at the mPOA via the injector cannula. 
Soon after the drug injection, the recordings was continued 
for 180 min (3 hr) . The paper speed was kept at lOmm/sec 
speed. Behaviour of the animal, like movements, posture, 
grooming, sniffing and sleep were noted down visually. The 
records were properly labeled. Calibration was taken before 
and after every experiment. 
(e) Method of intracerebral microinjection; 
After 90 min of preinjection recording, intracerebral 
microinjection of various drugs were administered. The 
microinjection set up consisted of an injection cannula, a 
polyethylene tubing and a microlitre syringe (Fig 4.1). The 
distance of the fluid movement to eject out 0.2ul was 
standardized in the polyethylene tubing and the respective 
distcince was marked. The required drug was drawn into the 
injector cannula and polyethylene tubing. On the distal end 
of the tubing (near th^ e microlitre syringe end) a small air 
bubble was introduced to monitor the fluid movement. Pressure 
was applied to the microlitre syringe. Before introducing 
Fig. 4.10: Animal af ter post-operat ive recovery 
Fig: 4 .11: Photomicrograph of a s e c t i o n showing 
i n j e c t i o n s i t e and the ex tens ion of drug 
diffusion (prussian blue area) a t the mPOA. 
AC - Anterior comniissure 

EOG 
EEG 
EMG 
AC Preamplifier 
Sensitivity - 150 uv/cm 
Low frequency pass - 0.3 Hz 
Time constant - 0.24 sec 
Sensitivity - 100 uv/cm 
Low frequency pass - 1 Hz 
Time constant - 0.1 sec 
Sensitivity - 30 uv/cm 
Low frequency pass - 3 Hz 
Time constant - 0.04 sec 
DC driver amplifier 
Polarity - Up 
High frequency pass - 15 Hz 
50 cycle filter - In 
Polarity - Up 
High frequency pass - 35 Hz 
50 cycle filter - Out 
Polarity - Up 
High frequency pass - 75 Hz 
50 cycle filter - Out 
TABLE 4.1 : Preamplifier setting for polysomnographic recording 
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into the brain, the patency of the injector cannula and the 
fluid movement was tested by ejecting out some fluid. The 
animal was gently restrained and the stylette was removed 
from the guide cannula. Injector cannula was then introduced 
into the guide cannula. This was followed by application of 
pressure to the microlitre syringe by the slow injector at a 
flow rate of O.lul/min. The volume of the injected drug 
injected was assessed on the basis of the movement of air 
bubble. The injector cannula was left in situ for atleast 2 
min to give sufficient time for the drug to diffuse into the 
surrounding brain tissue. This also helped in preventing the 
injected solution from being sucked back into the guide 
cannula at the time of withdrawal. Injector cannula was then 
replaced by the stylette. The same procedure was carried out 
for injection of the opposite side of the brain. The entire 
procedure took about 10 min. After the application of the 
drug the animal was gently let loose in the cage and the 
recording restarted. The post injection record was then 
carried out uninterrupted for 180 min. 
{f) Protocol; 
Details of the drug administered in the mPOA in 
different group of rats, time of study and dosage is 
mentioned in Table 4.2. The 24 rats were divided into foui 
groups of six each. Animals were left undisturbed (with 
plugged cables) in the recording cage for at least 30 min. 
This was followed by recordings of all the parameters for 90 
Group 
1 
2 
3 
4 
Number 
of rats 
6 
6 
6 
6 
Drug administered 
Saline 
Clonidine 
25% DMSO (vehicle) 
Yohimbine 
Amount 
0.2 ul 
2.0 ug in 0.2 ul 
0.2 ul 
1.0 ug in 0.2 ul 
Time of study 
10 .30- 17.30 h 
10.30- 17.30 h 
20.00 - 03.00 h 
20.00 - 03.00 h 
TABLE 4.2; Details of drug administration 
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min before, and 180 min after the injection of various drugs 
at the mPOA. The recording was started irrespective of the 
state of the animal (awake or asleep) in order to minimize 
the preinjection bias. Based on the preliminary experiments, 
the clonidine injection effect were studied during the light 
period (10.30 - 17.30h) and yohimbine during dark period 
(20.00 - 03.00h), to enhance the drug induced effects. (Drug 
induced arousal and sleep are better observed when the 
background preinjection record has higher percentage of 
sleep and wakefulness respectively). Details of the 
experimental plan is mentioned in Table 4.3. 
HISTOLOGY 
(a) Procedure for sacrificing the animal: 
At the end of the recording session, the animals were 
deeply anaesthetized with pentabarbitone sodium and 0.2ul of 
2% ferric chloride solution was injected into the mPOA 
through the guide cannula exactly as mentioned during the 
drug injection, using the same injector cannula. A midline 
incision was made after the animal was put in a supine 
position , to expose the heart. About 30 ml of 0.9% saline 
was perfused intracardially through the left ventricle. A 
small nick was made in the right auricle for the drainage of 
the perfusate. Following that, about 150-200 ml of 3% 
potassium ferrocyanide in 30% formaldehyde was perfused. The 
brain was then carefully removed and preserved in 10% 
SI. No. 
1 
2 
3 
4 
5 
6 
Days 
1 
2 
3-6 
7-8 
9 
10 
Time 
-
• -
09 .30 - 12.30 h 
03 .00 - 17.30 h 
10 .30- 17.30 h 
20.00 - 03.00 h 
10 .30- 17.30 h 
20.00 - 03.00 h 
-
Experimental procedure 
Selection of animals, labelling 
and housing them separately 
Induction of pentabarbitone 
anaesthesia and implantation 
of guide cannulae for 
microinjection of drugs into 
the mPOA and electrodes for 
recording EEG, EMG and EOG 
Animal periodically monitored. 
Assessment of post-operative 
recovery by observing the 
body temperature, food-water 
intake and general behaviour 
of the animal 
Familiarizing the animal wi th 
the recording cage 
Polysomnographic recording 
of sleep-wakefulness for 90 
min before and 180 min after 
respective drug injection 
Sacrificing the animal to 
ascertain the site of 
microinjection 
TABLE 4.3 : Experimental protocol 
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formaldehyde solution for 1-2 days (Bagga et al., 1981; Bagga 
et al., 1984). 
(b) Histological method employed to verify injection site: 
A small piece of the fixed brain tissue including the 
site of injection and its surrounding area was cut, processed 
and embedded in paraffin wax. Briefly, the tissue was washed 
in running water for 6-8 hrs. Then it was transferred 
overnight in 70% alcohol. Then it was placed in 100% alcohol 
(2 Changes), dehydrated in acetone (2 changes for two minutes 
each) , cleared with xylene for 15 min and then embedded in 
paraffin wax (3 changes) before the block was made. Serial 
sections of 10 um thickness were then cut on rotary 
microtome. Sections were then stained with hematoxilin and 
eosin, to identify the brain area and to provide contrast to 
the site of injection, visible as Prussian blue spot. 
Preparation of Eosin: Dissolved 4 gms of eosin in 320 ml 
distilled water and added 1280 ml of absolute alcohol. 16 
drops of acetic acid was also added. 
Preparation of Hematoxilin: Dissolved 10 gms of hematoxilin 
in 500 ml of alcohol. Added 500 ml of glycerin and 500 ml of 
distilled water. 50 gms of potassium alam was also added. 
Finally, 50 ml of glacial acetic acid was added. It was used 
after 3 months. 
The cut sections were put in xylene for 15 min (to 
remove wax) . It was then slowly hydrated with different 
grades of alcohol (100%, 90%, 70%) and distilled water for 1 
57 
min. The section were first stained with hematoxilin (2 min) . 
It was then washed in running water for 2 min and then 
stained with eosin for 2 min. The sections were then 
dehydrated with different grades of alcohol (70%, 90%, 100% -
just dip) and acetone. Stained sections were cleared in 
Xylene and mounted in DPX for microscopic examination. The 
presence and extension of Prussian blue coloration 
represented the site and spread of the injected drug. Only 
those rats where the prussian blue colour spots were confined 
to mPOA were considered in this study for further analysis 
(Fig 4.11) . 
ANALYSIS OF DATA 
(a) Scoring and analysis of S-W data; 
S-W was quantified on the basis of continuous 
records of EEG, EMG and EOG. A brief description of the 
analysis is given below. 
1.Analysis of EEG : The EEG recordings were obtained on the 
paper using the polygraph. The speed of the paper was kept at 
10 mm/sec for most of the recordings. At this speed it was 
possible to determine the frequency and duration of waves. 
The frequency of EEG waves was determined on the basis of 
measurement of the number of waves recurring at a period of 
1 sec. Amplitude was determined by measuring peak to peak 
voltage. Fast waves of low amplitude present in the awake 
phase had a frequency of 30-40 /sec and the amplitude was 
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nearly 30 uV, The amplitude of the slow waves ranged from 50 
to 300 uV and their frequency from 6 to 12/sec. The final 
assessment of classification of S-W stages was based on 
simultaneous additional information obtained from EMG, EOG 
and observations of behaviour. 
2, Analysis of EMG : EMG recorded from the dorsal nuchal 
muscles, with macroelectrodes in the present study consisted 
of "interference pattern" tracing. Thus, there was an 
increase or decrease in the amplitude of summated potential 
of the EMG with simultaneous increase or decrease in the 
tension of the muscle. 
3 .Analysis of EOG : Analysis of EOG was done qualitatively. 
The record of EOG, obtained through electrodes placed on the 
external canthus of the eye, showed spike like waves, with 
the movement of eyeballs occurring during wakefulness and 
paradoxical sleep. During paradoxical sleep, EOG waves were 
relatively regular and rapid but during awake period these 
waves were irregular. 
4.Quantification of sleep-wakefulness : For quantification 
of S-W, the electrophysiological observations were correlated 
with simultaneous behavioral observations. The entire 
polysomnographic record was split into 30 second epochs and 
visually scored. Each epoch was included in a particular 
stage of S-W depending on the stage to which more than 15 sec 
of the record belonged. Each epoch was classified as one of 
Fig. 4.12: EOG, EEG and EMG tracings during different 
stages of sleep-wakefulness. The timer (T) 
shows 1/sec signal. Cal bar: 600 uv (EOG) , 
300 uv (EEG), 200 uv (EMG). 
Wl 
i EOG 
T 
EEG 
lllliiWi>i|l|i||l|||hMm"»"i'l>»iii EMG 
W2 SI 
»^|p»w».*(wioii iffiMyiil W^'f< ri"H'WlwN*»i—>*¥ 
PS 
/^~vV/v 
M 
59 
the five different stages of S-W (Panksepp et al., 1973; 
Mohan Kumar et al., 1993). 
Wakeful state was classified into two stages, viz., 
active wakefulness (Wl), and quiet wakefulness (W2). Sleep 
state was classified into three different stages, viz., 
light slow wave sleep (SI) , deep slow wave sleep (S2) , and 
paradoxical sleep (PS) or rapid eye movement (REM) sleep (Fig 
4.12) . 
Classification of different stages of sleep-wakefulness (S-W) 
Polygraphic recordings which were divided into 30 sec 
epochs were visually scored as per criteria given below. 
(a) Active wakefulness (Wl) : EEG during Wl stage had low 
amplitude, high frequency (desynchronized) waves. EMG and 
EOG records had gross body movement artifact and high 
amplitude spiky waves produced by eyeball movement 
respectively. Animals showed sniffing, grooming, scratching, 
and orienting activities during this period. 
(b) Quiet wakefulness (W2): During W2, EEG remained 
desynchronized. Though the EMG remained high, it did not show 
any movement artifact. Spiky waves and slow rolling movements 
produced by the eyeballs were occasionally recorded. No 
locomotor activity was present, and the animals were found 
sitting quietly during this period. 
(c) Light slow wave sleep (SI) : SI stage was characterized 
by low frequency, high amplitude (synchronized) EEG spindle 
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waves. There was considerable reduction in EMG activity, and 
absence of locomotor activity. EOG did not snow much 
activity. The rats assumed a sleeping posture during this 
period. 
(d) Deep slow wave sleep (S2) ; S2 was characterized by 
continuous electro-cortical slow wave activity, where 
synchronized waves were not seen as separate spindles. There 
was further reduction in EMG as compared to that during SI. 
EOG activity was absent. 
(e) Paradoxical sleep stage (PS) : The PS or REM sleep was 
characterized by desynchronized EEG, drastic reduction in EMG 
(muscle atonia). The EOG showed spiky waves. 
There was a deviation from the normal criteria for 
classification of sleep-wakefulness, while analyzing the data 
after clonidine administration, as the EEG showed 
synchronization when the animal was behaviourally awake. So 
the scoring of sleep-wakeful stages in this pajrticular 
instance was done on the basis of non-EEG pcirameters. 
(b) Statistical analysis: 
The recordings were divided into bins of 5 min 
each. The preinjection and postinjection data were tabulated 
for statistical analysis. The preinjection data from each 
group of animals were analysed by Friedman's two way analysis 
of variance to assess if there was any significant variation 
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within the groups. The preinjection values from control 
groups (i.e. saline and DMSO injected animals) were compared 
with each of their postinjection readings to find out the 
effect of injection procedure on sleep-wakefulness, by using 
Friedman's multiple range test. Each bin of saline 
administration group (group 1) was compared with an identical 
period of clonidine administration group (group 2), and 
similarly DMSO group (group 3) with yohimbine group (group 
4) , using Wilcoxon's two-sample Rank (Mann-Whitney) ,test. 
This helped to compare the effects of administrations of 
clonidine and yohimbine with their respective vehicles. 
CHAPTER 5 
RESULTS 
RESULTS 
The aim of this study was to find out the possible role 
of alpha-2 receptors in the regulation of S-W. The 
experiments were carried out in four groups of rats. Apart 
from the group 1 and group 3 which were used as controls, the 
other two groups, group 2 and group 4 were studied to find 
out the effects in S-W after injection of clonidine, an 
alpha-2 agonist, and yohimbine, an alpha-2 antagonist, 
respectively. 
The preinjection values (of wakeful periods), obtained 
from different animals of each group, over a period of 90 
min, did not show significant difference, indicating that the 
rats, within each group, were comparable. In other words, 
there was no time dependent change (except the normal 
polycyclic sleep-awake pattern) in S-W over the period of 90 
min before the injection of various drugs. The details of the 
results are discussed as under: 
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(1) Group 1;- Effect of saline injection at the mPOA on 
sleep-wakefulness; 
Injection of saline (group 1) during the day, produced 
short-lasting arousal for about 15 min, probably due to the 
handling of the animals for injection (Fig. 5.1a and Table 
5.1a). These rats went back to the preinjection state after 
that period. 
On an average, these rats were awake for 49.25% of the 
total postinjection recording time of 180 min (3 hrs) . They 
spent 50.74% of the remaining time in sleep. Active 
Wakefulness (Wl) stage (Fig. 5.2a and Table 5.2a) occupied 
most of the postinjection awake period (36.06%). On the 
other hand, the Quiet Wakefulness (W2) was observed for only 
13.19% of the total recording time (Fig. 5.3a and Table 
5.3a). The Light Slow Wave sleep (SI) stage predominated 
the sleep period (Fig. 5.4a and Table 5.4a) with 38.56% of 
the recording time. Small percentages (9.81% and 2.36% of the 
time respectively) of Deep Slow Wave sleep (S2) and 
Paradoxical sleep (PS) were also recorded (Figs. 5.5a, 5.6a 
and Tables 5.5a and 5.6a). 
(2) Grovtp 2;- Effect of clonidine injection at the mPOA on 
sleep-waXefulness; 
The injection of clonidine in the mPOA (group 2), 
produced arousal. The rats were awake for 77.40% of the 
time and asleep for 22.59% of time. The values of awake 
periods were significantly increased from 10 to 70 min when 
A 
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Injection 
Fig. 5.2 : The bar diagrams show the effect of 
application of saline (A) and clonidine (B), 
during the light period, in the mPOA, on Wl 
stage. Injection point is indicated by an 
arrow, Y axis shows the awake period in 
minutes. Each bar is of 5 min bin. Data are 
mean ± SD. * p<0.05. 
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Fig. 5.7 : The left tracings (1) shows EOG (0),, EEG (E) 
and EMG (M) record from a normal sleeping 
rat. The tracings on the right (2) shows 
recordings ftom the same animal after 
clonidine injection. Here the EEG record 
showed synchronized waves when the animal was 
behaviourally awake. (Note the lower 
frequency and higher amplitude of the 
synchronized waves in this tracing). The 
timer (T) shows 1/sec signal. Cal bar : 600 
UV (EOG), 300 uv (EEG), 200 UV (EMG). 
Fig. 5.8 : Shows the photograph of an animal after 
injection of clonidine. Note the wide open 
eyes and general arousal. 
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compared to identical timings of the saline treated animals 
(Fig. 5.1b and Table 5.1b). 
There was a dissociation between behavioural arousal 
and EEG changes after injection of clonidine. Though the EEG 
showed synchronized waves after injection of clonidine, the 
EMG, EOG and behavioural observations indicated that the rats 
were awake. Dissociation between behaviour (arousal) and EEG 
(synchronization) was observed in all the six animals in 
group 2. This dissociation between EEG and behaviour and the 
non-EEG parameters of recording, were taken into 
consideration while classifying them as wakefulness. The 
synchronized EEG waves obtained after injection of clonidine 
were not identical to that observed during normal sleep. The 
frequency of the synchronized waves obtained after clonidine 
administration had a slightly lower mean frequency (8.66 ± SD 
0.75) compared to the synchronized waves obtained during true 
sleep (10.94 ± SD 0.45). The amplitude of these waves were 
also generally higher (Fig. 5.7). These rats had wide open 
eyes with dilated pupils (Fig. 5.8). Exaggerated 'sniffing' 
behaviour was seen in four out of six animals after clonidine 
injection. Normal exploratory movements, licking and grooming 
were also observed. Some rats were eating food during the 
course of the experiment. But most of the rats were 
remaining stationary with random head movements. Since there 
were no gross body movements, these stages could be described 
as quiet wakefulness, and were classified as W2, as per the 
Fig. 5.6 : The bar diagrams show the effect of 
application of saline (A) and clonidine (B) , 
during the light period, in the mPOA, on PS 
stage. Injection point is indicated by an 
arrow. Y axis shows the awake period in 
minutes. Each bar is of 5 rain bin. Data are 
mean ± SD. 
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Fig. 5.5 : The bar diagrams show the effect of 
application of saline (A) and clonidine (B) , 
during the liglit period, in the mPOA, on S2 
stage. Injection point is indicated by an 
arrow. Y axis shows the awake period in 
minutes. Each bar is of 5 min bin. Data are 
mean ± SD. * p<0.05. 
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criteria given by John et al., 1994, 
The different stages of S-W were compared with saline 
control group to find out the component of these S-W stages 
which were significantly affected. There was no significant 
change in the Wl stage after injection of clonidine, when the 
total post injection records were compared (Fig. 5.2b and 
Table 5.2b). The animals were in Wl stage for 39.39% of the 
recording time. There was a significant increase in Wl at 65-
70 min bin and a significant decrease at 160-165 min bin 
periods. However, these changes were neither injection bound 
nor obtained on continuous bins. 
When W2 stage was compared with saline control, the 
data showed significant increase in this stage from 10 to 55 
min (Fig. 5.3b and Table 5.3b). In addition, isolated 
significant alterations in S-W at 60-65 min, 90-95 min, 115-
120 rain and 145-155 min bins were also obtained. The rats 
were in W2 stage for 38.00% of the recording time as compared 
to only 13.19% in saline control group. 
The SI stage was decreased significantly (Fig 5.4b and 
Table 5.4b) from 10 to 70 min after the injection. Total 
percentage time the rats spent in SI after the injection was 
about 14.12% as compared to 38.56% in the saline control 
grovap. There was no injection bound change in S2 stage (Fig. 
5.5b and Table 5.5b), though there was significant decrease 
at 55-65 min, 90-100 min and increase at 165-170 min. The 
Fig. 5.11;; The bar diagrams show the effect of 
application of 25% DMSO (A) and yohimbine 
(B) , during the dark period, in the mPOA, on 
W2 stage. Injection point is indicated 
by an arrow. Y axis shows the awake period in 
minutes. Each bar is of 5 min bin. Data are 
mean ± SD. * p<0.05. 
Fig. 5.10: The bar diagrams show the effect of 
application of 25% DMSO (A) and yohimbine 
(B) , during the dark period, in the mPOA, on 
Wl stage. Injection point is indicated 
by an arrow. Y axis shows the awake period in 
minutes. Each bar is of 5 min bin. Data are 
mean ± SD. * p<0.05 ** p<0.01. 
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Fig. 5.9 : The bar diagrams show the effect of 
application of 25% DMSO (A) and yohimbine 
(B) , during the dark period, in the mPOA,, on 
sleep-wakefulness. Injection point is 
indicated by an arrow. Application of 
yohimbine produced decrease in wakefulness 
(ie. induced sleep) when compared to its 
vehicle control (DMSO). Y axis shows the 
awake period in minutes. Each bar is of 5 min 
bin. Data are mean ± SD. *, p<0.05 ** 
p<0.01,. 
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Fig. 5.14: The bar diagrams show the effect of 
application of 25% DMSO (A) and yohimbine 
(B) , during the dark period, in the mPOA, on 
PS stage. Injection point is indicated 
by an arrow. Y axis shows the awake period in 
minutes. Each bar is of 5 min bin. Data are 
mean ± SD. * p<0.05 ** p<0.01. 
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percentage of S2 during the entire postinjection period, in 
both the clonidine group and saline group, were almost the 
same (8.00% and 9.81% respectively). No significant change 
was observed in the PS stage (Fig. 5.6b and Table 5.6b). The 
rats spent about 0.46% of the postinjection period in this 
stage. 
(3) Group 3;- Effect of vehicle (DMSO) injection at the mPOA 
on sleep-wakefulness; 
The administration of the vehicle of yohimbine, i.e. 
25% dimethyl sulfoxide (DMSO), produced no change in normal 
pattern of sleep-wakefulness (Fig. 5.9a and Table 5.9a). The 
basal recording of S-W during the night (DMSO was injected 
during the dark period), showed that the rats were awake for 
77.73% of the total recording time as compared to 49.25% 
during the day (saline group). On the other hand, on an 
average, it was asleep only for 22.26% of the recording time 
during the night as compared to 50.74% during the light 
period (Group 1). 64.21% of this awake period was spent in Wl 
stage (Fig. 5.10a and Table 5.10a) and the rest 13.51% was 
spent in W2 stage (Fig. 5.11a and Table 5.11a). 20.04% of the 
sleep period was occupied by SI stage (Fig 5.12a and Table 
5.12a). The time spent in S2 stage (5.13a and Table 5.13a) 
and PS stage (Fig. 5.14a and Table 5.14a) were very low 
(1.48% and 0.74% were spent in S2 and PS respectively). 
PREINJECTION POSTINJECTION 
TIME (Mini 
0-5 
5-10 
10-1 5 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80 85 
85 90 
M E A N 
4.00 
3.41 
2.75 
3.25 
3.00 
2.33 
3.66 
3. 1 6 
1 .75 
2.58 
3. 16 
2.66 
2.75 
2.91 
3.50 
2.41 
1 .00 
2.16 
± SD 
0.67 
0.76 
0.56 
0.79 
0.62 
0.66 
0.72 
0.76 
0.62 
0.72 
0.74 
0.61 
0.67 
0.60 
0.78 
0.79 
0.46 
0.58 
TIME (Min) 
0-5 
5-10 
10-1 5 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95-100 
1 00-1 05 
105-110 
110-115 
115-120 
1 20-1 25 
1 25-1 30 
1 30-1 35 
1 35-1 40 
140-145 
1 45-1 50 
1 50-1 55 
1 55-160 
1 60-1 65 
1 65-1 70 
1 70-1 75 
175-180 
M E A N 
5.00 
4.66 
3.66 
2. 1 6 
2.91 
3.25 
2.58 
2.00 
2.58 
2.83 
2.58 
2.50 
1 .91 
1 .83 
3.00 
3.50 
1 .83 
2.75 
1 .83 
2.25 
3.41 
2.58 
1.91 
2.58 
2.16 
1 .58 
1 .41 
1 .66 
2.58 
3.00 
2.08 
2.66 
1 .08 
1 .33 
1 .25 
1 .66 
± SD 
0.00 
0.20 
0.57 
0.64 
0.69 
0.67 
0.56 
0.67 
0.57 
0.49 
0.70 
0.75 
0.63 
0.78 
0.76 
0.63 
0.69 
0.84 
0.82 
0.48 
0.68 
0.63 
0.52 
0.68 
0.57 
0.38 
0.55 
0.56 
0.65 
0.67 
0.79 
0.64 
0.29 
0.40 
0.50 
0.43 
TAISLE 5 la : Shows the mean value and the standard deviation for awake period for ever\ 5 niin 
bins before and after injection ornonnai saline 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-1 0 
10 -1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
80 85 
8 5 - 9 0 
M E A N 
4 . 2 5 
3 . 0 0 
2 . 7 5 
1 .41 
3 . 3 3 
2 . 5 8 
3 .16 
2 . 5 0 
2 . 0 8 
2 . 4 1 
3 .16 
3 .75 
2 . 5 0 
3 ,16 
1 .66 
1 .83 
2 . 5 0 
1 .91 
± SD 
0 . 2 9 
0 . 7 4 
0 .62 
0 . 2 4 
0 . 5 9 
0 . 7 1 
0 . 6 9 
0 .57 
0 .68 
0 .67 
0 .74 
0 .62 
0 .69 
0 . 8 3 
0 .63 
0 .78 
0 . 5 9 
0 .75 
TIME (Min) 
0-5 
5-10 
10 -15 
15 -20 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
70 75 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
1 0 0 - 1 0 5 
105-1 10 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 20-1 25 
1 25 -1 30 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
140 -1 45 
145 -1 50 
1 50 -1 55 
1 5 5 - 1 6 0 
160 -1 65 
1 6 5 - 1 70 
1 70 -1 75 
1 7 5 - 1 8 0 
M E A N 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
5 . 0 0 
4 .9 1 
5 . 0 0 
5 . 0 0 
4 . 8 3 
4 . 5 0 
3 .66 
3 .33 
3 . 0 0 
3 .33 
3 . 5 0 
4 . 3 3 
3 . 5 0 
3 . 0 0 
1 .66 
1 .75 
3 . 5 0 
2.1 6 
2 . 5 0 
0 .4 1 
1 .83 
1 .75 
1 .83 
± SD 
0 . 0 0 
0 . 0 0 
0 . 0 0 * 
0 . 0 0 * * 
0 . 0 0 * * 
0 . 0 0 * • 
0 . 0 0 * * 
0 . 0 0 * • 
0 . 0 0 * • 
0 . 0 0 * * 
0 . 0 0 * * 
0 . 0 0 * 
0 . 0 0 * * 
0 . 0 0 * • 
0 . 0 7 
0 . 0 0 
0 . 0 0 * * 
0 . 1 3 
0 . 2 8 
0 . 4 2 
0 . 4 4 
0 . 7 4 
0 . 6 9 
0 . 5 6 
0 . 4 7 • 
0 . 6 6 
0 . 5 3 * 
0 . 4 8 
0 . 6 2 
0 . 3 9 
0 . 4 4 
0 . 4 7 
0 . 3 4 
0 . 6 2 
0 . 7 9 
0 . 5 4 
TABLE 5.1b : Shows Ihe mean value and the standard deviation for awake period for every 5 nun 
bins before and after injection of clonidine • p < 0.05 ** p < 0 01 
TIME (Min) 
0-5 
5-1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
75 8 0 
8 0 85 
85 90 
PREINJECTION 
M E A N 
2 . 5 0 
2 . 3 3 
1 .58 
1 .66 
2 . 0 8 
1 .91 
3 . 2 5 
2 . 6 6 
1 .33 
1 .58 
2 . 3 3 
1 .41 
1 . 5 0 
1.91 
2 . 8 3 
1 . 5 0 
0 .4 1 
1 .83 
± SD 
0 .66 
0 .62 
0 . 4 3 
0 . 5 6 
0 . 4 8 
0 .69 
0 .69 
0 . 7 0 
0 .62 
0 .64 
0 .55 
0 .34 
0 .55 
0 .51 
0 . 7 0 
0 .51 
0.1 9 
0 .65 
TIME (Min) 
0-5 
5 -10 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
90 95 
9 5 - 1 0 0 
1 0 0 - 1 05 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 25 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 45 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 65 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
POSTINJECTION 
M E A N 
3 .83 
3.1 6 
2 . 8 3 
1 .33 
2 . 5 0 
2 . 0 8 
1 .91 
1 .66 
2 . 1 6 
2 . 5 0 
2 . 0 8 
1 .83 
1 . 0 0 
1 .25 
1 .91 
2 . 5 0 
1 .41 
1 .50 
1 .58 
1 .08 
2 . 6 6 
1 .66 
1.33 
2 . 0 0 
1.75 
0 . 7 5 
1 .08 
1 .33 
1 .83 
2 . 5 8 
1 .83 
1 .75 
1 .08 
1 . 0 0 
0 . 5 8 
1 . 5 0 
± SD 
0 . 4 3 
0 . 5 4 
0 . 5 6 
0 . 6 2 
0 . 6 1 
0 . 5 8 
0 . 5 2 
0 . 6 7 
0 . 5 8 
0 . 5 1 
0 . 5 9 
0 . 5 3 
0 . 2 9 
0 . 6 9 
0 .6 0 
0 . 5 1 
0 .6 3 
0 .5 5 
0 .7 1 
0 . 2 2 
0 . 6 4 
0 .5 7 
0 . 4 0 
0 . 7 2 
0 . 4 0 
0 . 2 7 
0 . 3 8 
0 . 4 4 
0 . 5 6 
0 . 5 9 
0 . 7 7 
0 . 5 1 
0 . 2 8 
0 . 3 9 
0 . 1 9 
0 . 4 3 
TABUi 5.2a Shows tlic nicaii value aiid Uic .standard deviation Ibr Active Wakerulncs.s (Wl) for 
every 5 min bins before and arter injeclion olnonnal saline 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
M E A N 
2 . 7 5 
2 . 8 3 
1 . 4 1 
0 . 5 8 
2 . 1 6 
2 . 1 6 
1 . 5 8 
1 . 2 5 
1 . 2 5 
1.9 1 
2 . 5 0 
2 . 7 5 
1 . 3 3 
2 . 2 5 
1 . 1 6 
1 . 1 6 
1 . 3 3 
1 . 4 1 
± SD 
0 . 5 2 
0 . 8 0 
0 . 4 1 
0 . 1 9 
0 . 7 0 
0 . 7 3 
0 . 4 9 
0 . 4 9 
0 . 6 9 
0 . 7 4 
0 . 7 6 
0 . 5 4 
0 . 5 1 
0 . 6 6 
0 . 6 3 
0 . 6 4 
0 . 6 6 
0 . 5 8 
TIME (Min) 
0 -5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
1 0 0 - 1 0 5 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 25 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 55 
1 5 5 - 1 6 0 
1 6 0 - 1 65 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
M E A N 
3 . 9 1 
2 . 5 0 
1 . 5 8 
1 . 8 3 
1 . 5 0 
1 . 8 3 
2 . 5 0 
2 . 4 1 
2 . 6 6 
1 . 7 5 
1 . 5 8 
3 . 0 0 
2 . 5 0 
2 . 9 1 
2 . 7 5 
2 . 9 1 
2 . 8 3 
2 . 2 5 
1 . 6 6 
1.9 1 
1 . 6 6 
1 . 3 3 
1 . 7 5 
1 . 7 5 
2 . 9 1 
2 . 0 0 
2 . 0 8 
1 , 3 3 
1 . 0 8 
1 . 8 3 
1 . 3 3 
1 . 0 8 
0 . 2 5 
1 . 2 5 
1 . 3 3 
± SD 
0 . 4 5 
0 . 5 9 
0 . 3 8 
0 . 2 5 
0 . 2 7 
0 . 5 5 
0 . 5 9 
0 . 6 0 
0 . 6 1 
0 . 6 2 
0 . 4 3 
0 . 5 6 
0 . 6 4 
0.55 • 
0 . 6 0 
0 . 6 5 
0 . 7 5 
0 . 5 0 
0 . 3 2 
0 . 6 2 
0 . 3 7 
0 . 5 8 
0 . 4 8 
0 . 6 2 
0 . 6 4 
0 . 6 6 
0 . 6 7 
0 . 4 4 
0 . 6 1 
0 . 4 7 
0 . 4 0 
0 . 3 8 
0.20 • 
0 . 4 5 
0 . 6 2 
1 . 0 8 0 . 3 8 
TABLE 5.2b Shows the mean value and 
every' 5 min bins before and 
Ihe standard deviation for 
after injection of clonidine 
Active Wakefulness (Wl) for 
• p < 0.05 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5 10 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
6 0 6 5 
6 5 7 0 
7 0 7 5 
7 5 8 0 
8 0 8 5 
8 5-90 
MEAN 
1.50 
1.08 
1.16 
1.58 
0.91 
0.41 
0.41 
0.50 
0.41 
1.00 
0.83 
1 .25 
1 .25 
1.00 
0.66 
0.91 
0.58 
0.33 
± SD 
0.61 
0.38 
0.38 
0.53 
0.28 
0.26 
0.34 
0.25 
0.16 
0.52 
0.27 
0.41 
0.48 
0.38 
0.40 
0.45 
0.27 
0.20 
TIME (Min) 
0-5 
5-10 
10-1 5 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70 75 
75 80 
80 85 
85 90 
90 95 
95-100 
100 105 
105-110 
110-115 
1 1 5-120 
1 20-1 25 
125-130 
13 0-135 
1 35-140 
140-145 
145-1 50 
150-155 
155-160 
160-165 
165-170 
1 70-175 
1 75-180 
MEAN 
1.16 
1.50 
0.83 
0.83 
0.41 
1.16 
0.66 
0.33 
0.41 
0.33 
0.50 
0.66 
0.91 
0.58 
1.08 
1.00 
0.4 1 
1 .25 
0.25 
1.16 
0.75 
0.91 
0.58 
0.58 
0.41 
0.83 
0.33 
0.33 
0.75 
0.41 
0.25 
0.91 
0.00 
0.33 
0.66 
0.16 
± SD 
0.43 
0.49 
0.37 
0.34 
0.22 
0.40 
0.25 
0.13 
0.12 
0.20 
0.21 
0.40 
0.46 
0.30 
0.54 
0.1 8 
0.34 
0.59 
0.20 
0.29 
0.25 
0.40 
0.34 
0.16 
0.19 
0.27 
0.20 
0.20 
0.1 3 
0.12 
0.09 
0.3 5 
0.00 
0.1 3 
0.40 
0.13 
['AHIM 5 3a : Shows Uic incaii value and llic standard deviation for Quiet Wakefulness (W2) for 
ever>' 5 min bins before and after injection of noraial saline 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
M E A N 
1 . 5 0 
0 . 1 6 
1 . 3 3 
0 . 8 3 
1 . 1 6 
0 . 4 1 
1 . 5 8 
1 . 2 5 
0 . 8 3 
0 . 5 0 
0 . 6 6 
1 . 0 0 
1 . 1 6 
0 . 9 1 
0 . 5 8 
0 . 6 6 
1 . 1 6 
0 . 5 0 
± SD 
0 . 3 1 
0 . 0 8 
0 . 3 7 
0 . 2 9 
0 . 2 2 
0 . 1 9 
0 . 3 8 
0 . 4 6 
0 . 4 5 
0 . 1 8 
0 . 2 9 
0 . 2 7 
0 . 5 6 
0 . 3 4 
0 . 2 4 
0 . 4 6 
0 . 3 7 
0 . 1 8 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
1 0 0 - 1 0 5 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 2 5 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
1 6 5 - 1 7 0 
1 7 0 - 1 75 
1 7 5 - 1 8 0 
M E A N 
1 . 0 8 
2 . 5 0 
3 . 4 1 
3 . 1 6 
3 . 5 0 
3 . 1 6 
2 . 5 0 
2 . 5 8 
2 . 3 3 
3 . 2 5 
3 . 4 1 
2 . 0 0 
2 . 5 0 
2 . 0 8 
2 . 1 6 
2 . 0 8 
2 . 1 6 
2 . 5 8 
2 . 8 3 
1 . 7 5 
1 . 6 6 
1 . 6 6 
1 . 5 8 
1 . 7 5 
1 . 4 1 
1 . 5 0 
0 . 9 1 
0 . 3 3 
0 . 6 6 
1 . 6 6 
0 . 8 3 
1 . 4 1 
0 . 1 6 
0 . 5 8 
0 . 4 1 
0 . 7 5 
± SD 
0 . 4 5 
0 . 5 9 
0 . 3 8 • * 
0 . 2 5 • * 
0 . 2 7 • • 
0 . 5 5 * 
0 . 5 9 * 
0 . 6 0 * 
0 . 6 1 • 
0 . 6 2 • • 
0 . 4 3 • • 
0 . 5 6 
0 . 6 4 • 
0 . 5 5 
0 . 5 9 
0 . 6 5 
0 . 7 5 
0 . 4 6 
0 . 4 3 • ' 
0 . 4 8 
0 . 3 8 
0 . 6 4 
0 . 4 5 
0 . 4 4 • 
0 . 4 1 
0 . 5 2 
0 . 1 9 
0 . 0 8 
0 . 2 2 
0 . 4 0 * 
0 . 1 3 * 
0 . 2 2 
0 . 1 3 
0 . 1 9 
0 . 1 6 
0 . 2 0 
lABLE 5..i;b : Shows the mean value and the standard deviation for Quiet Wakefuhiess (W2) for 
every 5 min bins before and after injection of clonidine * p < 0 . 0 5 •*p<0.01 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-1 0 
10-15 
15-20 
2 0-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60 65 
65 70 
70 75 
75 80 
80 85 
85-90 
M E A N 
0.91 
0.08 
1.25 
1 .50 
1 .58 
1.33 
0.83 
1 .58 
2.50 
1 .83 
1 .50 
1.75 
0.9 1 
1 .4 1 
1.4 1 
2.16 
2.4 1 
2.08 
± SD 
0.60 
0. 1 1 
0. 1 6 
0.66 
0.4 1 
0. 1 5 
0.60 
0. 64 
0.53 
0.58 
0.58 
0.37 
0.11 
0.37 
0,74 
0.65 
0.57 
0.42 
TIME (Min) 
0-5 
5-1 0 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75 80 
80-35 
85-90 
90-95 
95-100 
1 00- 1 05 
1 0 5 1 1 0 
110-115 
1 15-120 
1 20- 1 25 
12 5-130 
130-135 
135-140 
1 40- 1 45 
145-150 
150-155 
155-160 
1 60-165 
165-170 
1 70- 1 75 
175-180 
M E A N 
0.00 
0.33 
1.33 
2.83 
2.08 
1 .58 
2.41 
2.50 
1.83 
1 .50 
1 .50 
1 .60 
2.25 
2.08 
0.83 
1 .25 
2.83 
1.4 1 
2.00 
1.91 
0.75 
2.00 
2.26 
2.25 
2.41 
2.75 
2.75 
2.16 
1 .66 
1 .50 
2.41 
2.16 
3.00 
2.4 1 
2.25 
2.66 
± SD 
0.00 
0.20 
0.57 
0.63 
0.69 
0.57 
0.56 
0.55 
0.40 
0. 1 4 
0.49 
0.47 
0.50 
0.58 
0.37 
0.49 
0.62 
0..6 1 
0.62 
0.38 
0.34 
0. 54 
0.20 
0.62 
0.74 
0.27 
0.43 
0.27 
0.45 
0.43 
0.76 
0.57 
0.34 
0.5 1 
0.27 
0.34 
TABLE 5.4a : Shows the mean value and Uie standard deviation for LiglU .Slov\'Wave Sleep (SI) for 
every 5 min bms before and after injection of nonnal saline 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-2 5 
2 5-30 
30-35 
35-40 
40-45 
45-50 
50-55 
5 5-60 
6 0-65 
6 5 7 0 
7 0 7 5 
7 5-80 
80-85 
85-90 
M E A N 
0.75 
1,83 
1 .91 
1 .83 
1 .08 
1 .83 
0.83 
1 .50 
1 .41 
1 .58 
1 .08 
0.50 
1.16 
0.33 
1 .75 
1 .58 
1.16 
1.16 
± SD 
0.29 
0.70 
0.57 
0.25 
0.35 
0.57 
0.44 
0.39 
0.34 
0.51 
0.54 
0.27 
0.47 
0.27 
0.54 
0.64 
0.29 
0.22 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95-1 00 
100 1 05 
1 05-1 1 0 
110-115 
115-120 
1 20-1 25 
125-130 
130-135 
1 35-140 
1 40-1 45 
1 45-1 50 
150-155 
155-160 
1 60-1 65 
165-170 
170-175 
1 75-1 80 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.08 
0.00 
0.00 
0. 1 6 
0.50 
1 .25 
1 .66 
1 .83 
1 .08 
1 .00 
1 .58 
1 .00 
1 .50 
2.16 
2.33 
0.83 
1 .58 
2.00 
1 .83 
1.25 
1 .08 
1 .66 
± SD 
0.00 
0.00 
0.00* 
0.00* • 
0.00* • 
0.00* * 
0.00* • 
0.00* • 
0.00' • 
0.00' * 
0.00* 
0.00* 
0.00* • 
0.00* • 
0.06 
0.00 
0,00* ' 
0. 1 3 
0.27 
0.37 
0.4 4 
0.65 
0.37 
0.42 
0.40' 
0.52* 
0.55 
0.61 
0.58 
0.31 
0.2 6 
0.43 
0.49 
0.54 
0.54 
0.41 
TABLl- 5 -lb : Shows the mean value aiid the standard deviation for 
cvcr> 5 min bins before and atler injection of clonidine 
Liglit Slow Wave Sleep (S1) for 
• p<0.05 •*p<0.01 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
4 0-45 
4 5-50 
5 0-55 
5 5-60 
6 0-65 
6 5-70 
7 0 7 5 
7 5-80 
8 0-85 
8 5-90 
M E A N 
0.08 
1 .50 
1 .00 
0.25 
0.41 
1.16 
0.08 
0.25 
0.33 
0.58 
0. 1 6 
0.33 
1 .00 
0.25 
0.00 
0.33 
1.4 1 
0.56 
± SD 
0.06 
0.33 
0.60 
0.20 
0.34 
0.1 3 
0.06 
0.20 
0.17 
0.47 
0..1 3 
0.20 
0.60 
0.20 
0.00 
0.1 7 
0.52 
0.32 
TIME (Min) 
0-5 
5-10 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95-100 
100-1 05 
105-110 
110-115 
115-120 
1 20-1 25 
1 25-1 30 
1 30-1 35 
1 35-1 40 
1 40-1 45 
145-1 50 
1 50-1 55 
1 55-1 60 
1 60-1 65 
1 65-1 70 
1 70-1 75 
175-180 
MEAN 
0.00 
0.00 
0.00 
0.00 
0.00 
0.16 
0.00 
0.33 
0.25 
0.58 
0.91 
1 .00 
0.83 
0.58 
0.83 
0.25 
0.00 
0.75 
1.00 
0.66 
0.83 
0.33 
0.75 
0.1 6 
0.41 
0.50 
0.58 
0.83 
0.5S 
0.50 
0.41 
0.08 
0.91 
1 .00 
0.91 
0.66 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.13 
0.00 
0.20 
0.20 
0.32 
0.45 
0.38 
0.31 
0.40 
0.38 
0.20 
0.00 
0.34 
0.43 
0.20 
0.60 
0.20 
0,39 
0.08 
0. 1 9 
0.40 
0.1 2 
0.31 
0.26 
0.27 
0.34 
0.06 
0.34 
0.25 
0.28 
0.29 
lABi J{ 5.5a . Shows Ihe mean value aiid Ihe standard dcvialion for Deep Slow Wave Sleep (S2) lor 
ever>' 5 min bins before and after injeclion of iionnal saline 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-1 0 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
6 5-70 
7 0-75 
7 5-80 
80-85 
8 5-90 
M E A N 
0.00 
0.16 
0.33 
0.7 5 
0.58 
0.58 
0.75 
1.00 
1 .50 
1 .00 
0.50 
0.75 
1 .33 
1 .50 
0.83 
1 .58 
1.16 
1 .58 
+ SD 
0.00 
0.1 3 
0.17 
0.40 
0.30 
0.40 
0.27 
0.40 
0.58 
0.57 
0.40 
0.34 
0.62 
0.69 
0.3 8 
0.71 
0.50 
0.49 
TIME (Min) 
0-5 
5-10 
10-1 5 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95-100 
1 00-105 
105-110 
110-115 
1 1 5-1 20 
1 20-1 25 
125-1 30 
1 30-1 35 
135-140 
1 40-1 45 
145-1 50 
1 50-1 55 
1 55-160 
1 60-1 65 
165-1 70 
1 70-1 75 
175-180 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.08 
0.00 
0. 1 6 
0.58 
0.25 
0.08 
0.50 
0.50 
1.16 
0.66 
0.66 
1 .25 
0.50 
2.75 
1 .75 
2.00 
1 .50 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00* 
0.00' 
0.00 
0.00 
0.00 
0,00 
0.00 
0.00' 
0.06* 
0.00 
0. 1 3 
0.34 
0. 1 3 
0.06 
0.33 
0.25 
0.53 
0.46 
0.38 
0.45 
0.33 
0.65 • 
0.72 
0.81 
0.78 
TABLl: 5.5b : Shows tlie mean value aiid tlie standard deviation for I3eep Slow Wuve Sleep (S2) for 
every 5 min bins before and after injection of clonidine * p < 0.05 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
5 0-55 
55-60 
60-65 
65 70 
70 75 
75 80 
80 8 5 
8 5 90 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.16 
0.41 
0.00 
0.41 
0.00 
0.16 
0,25 
0.33 
0.41 
0.08 
0.08 
0.00 
0.08 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.1 3 
0.27 
0.00 
0.20 
0.00 
0.13 
0,19 
0.19 
0,20 
0.06 
0,06 
0,00 
0.06 
TIME (Mm) 
0-5 
5-10 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-5 5 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95-100 
100-105 
105-1 10 
110-115 
115-120 
1 20-1 25 
1 2 5 1 3 0 
130-135 
135-140 
1 40-1 45 
1 4 5 1 5 0 
1 50-1 55 
155-160 
1 60-1 65 
165-170 
1 70-1 75 
175-180 
M E A N 
0,00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.16 
0.33 
0,08 
0.00 
0.0 0 
0.00 
0,50 
0,33 
0,00 
0,33 
0.08 
0,16 
0.16 
0,08 
0,08 
0.00 
0.00 
0.16 
0,00 
0,25 
0,33 
0,16 
0,00 
0.08 
0.08 
0.00 
0.25 
0.58 
0.00 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.08 
0.20 
0.06 
0.00 
0.00 
0.00 
0.18 
0.20 
0.00 
0.2 1 
0.06 
0.08 
0.13 
0.06 
0.06 
0,00 
0,00 
0.13 
0.00 
0.13 
0.20 
0.13 
0.00 
0.06 
0.06 
0.00 
0.20 
0.06 
0.00 
I AHLi: 5.6a : Shows the mean value aiid llie .standard deviation for Parado.vical Sleep (I'S) lor 
every 5 inin bins before and after injection of nonnal saUne 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
1 5-20 
2 0-25 
2 5-30 
3 0-35 
3 5-40 
4 0-45 
45-50 
50-5 5 
55-60 
60-65 
65 70 
70 7 5 
75 80 
80-8 5 
8 5 90 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.25 
0.00 
0.00 
0.00 
0.25 
0.00 
0.00 
0.00 
0.66 
0.00 
0.16 
0.33 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.20 
0.00 
0.00 
0.00 
0.20 
0.00 
0.00 
0.00 
0.06 
0.00 
0.13 
0.20 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85 90 
90-9 5 
95-100 
100-105 
105-1 10 
110-115 
115-120 
120-125 
125-130 
130-135 
135-140 
140-145 
145-150 
150-155 
155-160 
160-165 
165-170 
170-175 
175-180 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0 ,00 
0.25 
0.00 
0.00 
0.00 
0.00 
0.25 
0.00 
0.00 
0.00 
0.00 
0.16 
0.16 
0.00 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.20 
0.00 
0.00 
0.00 
0.00 
0.20 
0.00 
0.00 
0.00 
0.00 
0.08 
0.13 
0.00 
TAlJLIi 5.6b : Shows tlic mean value and Uic stajidard deviation for Faradoxica! Slix-p (PS) for 
every 5 min bins before and afla injection of clonidnie 
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(4) Group 4;-- Affect of yohimbine injection at the mPOA on 
sleep-waXefulness; 
Yohimbine, an alpha-2 antagonist, when administered at 
the mPOA produced sleep (Fig. 5.15). It was significant from 
20 min to 120 min after the injection (Fig. 5.9b and Table 
5.9b). Significant changes were also observed at 125-130 min, 
150-155 min and 160-165 min bins. The animals assumed a 
"curled-up" or "lying-straight" posture during sleep, induced 
by yohimbine administration (Fig. 5.16). Episodes of 
paradoxical sleep (PS), though rare (average rate - 2.5 
episodes per hour), were also obtained after yohimbine 
administration. 
The rats spent only 29.49% of postinjection recording 
time in wakefulness as compared to 77.73% after DMSO 
administration in the control group. The total recording time 
was predominantly spent in sleeping (70.50%). 
The different stages of S-W was compared with the DMSO 
control group. Since the aniTnal went iniro injection bound 
sleep, only 20.18% of the total recording t±me was spent in 
Wl stage (Fig. 5.10b and Table S.lQb), and the rest 9.30% of 
Wci>:ef ulness was spent in W2 st:age (Fig. 5. lib and Table 
5.11b). There was a significant decrease in Wl from 20 to 115 
min. Significant alteration was also observed at 
discontinuous bins at 125-130 min, 140-145 min, 150-155 min, 
160-165 min and 170-175 min. Although no significant changes 
in continuous bins were observed in W2 stage, at 65-7 0 min. 
Fig. 5.15: The left tracings (1) shows EOG (0), EEG (E) 
and EMG (M) record, during dark period, from 
a awake rat before drug injection. The 
tracings from the same rat, on the right (2) 
obtained after 20 min of yohimbine injection, 
show induced slow wave sleep. The timer (T) 
shows 1/sec signal. Cal bar: 600 u,v (EOG) , 
300 uv (EEG), 150 uv (EMG). 
Fig. 5.16: Shows the photograph of an animal after 
injection of yohimbine. 
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85-95 min and 130-135 min bins it showed significant 
alterations. 
The animals spent most of the time in SI stage (57.03%) 
as compared to only 20.04% in vehicle control group (Fig. 
5.12b and Table 5.12b). The data showed significant increase 
in SI from 15 min to 115 min. Discontinuous bins at 140-145 
m.in, 150-155 min and 160-165 min also showed significant 
increase. 
The percentage of S2 stage was also increased (11.20%) 
as compared to the DMSO control group (1.48%). The S2 stage 
was significant in continuous bins from 90-110 min during the 
latter part of the induced sleep (Fig. 5.13b and Table 
5.13b). Isolated bins at 55-60 min, 70-75 min, 120-130 min 
and 150-155 min were also significant. 
There was no significant change in PS, except during 
70-75 min bin (Fig. 5,14b and Tcible 5.14b). The animals 
spent, on an average, 2.2 6% of the time in PS as compared to 
0.74% of the total recording time in vehicle control group. 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
M E A N 
4 .1 6 
4 . 0 0 
4 . 2 5 
4 . 4 1 
4 . 1 6 
4 . 0 8 
4 . 6 6 
4 . 5 0 
4 . 6 6 
4 . 2 5 
3 . 6 6 
3 . 6 6 
3 . 6 6 
3 . 9 1 
3 . 0 8 
4 . 0 8 
5 . 0 0 
4 . 2 5 
± SD 
0 . 6 0 
0 . 4 8 
0 . 3 9 
0 . 3 0 
0 .37 
0 . 4 1 
0 . 2 0 
0 . 3 3 
0.1 3 
0 . 3 9 
0 . 6 5 
0 . 5 9 
0 . 6 9 
0 . 4 7 
0 . 5 4 
0 . 3 7 
0 . 0 0 
0 . 5 3 
TIME (Min) 
0-5 
5 -10 
10 -15 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
1 0 0 - 1 0 5 
105 -1 10 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 20-1 25 
1 25-1 30 
1 30 -1 35 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 50 -1 55 
1 5 5 - 1 6 0 
1 60 -1 65 
165 -1 70 
1 70 -1 75 
1 75 -1 80 
M E A N 
5 . 0 0 
4 . 8 3 
4 . 8 3 
4 . 8 3 
3 . 9 1 
4 . 2 5 
4 . 5 8 
4 . 4 1 
4 . 4 1 
4 . 5 8 
4 . 5 0 
4 . 1 6 
3 . 6 6 
3 .75 
3.1 6 
3.9 1 
4 . 7 5 
4 . 8 3 
4 .4 1 
4 . 8 3 
4 . 9 1 
4 . 0 0 
3 . 5 0 
2 . 8 3 
2 . 8 3 
2 . 1 6 
2 . 0 0 
2 . 8 3 
2 . 7 5 
2 . 5 8 
4 . 0 8 
3 . 0 0 
3 . 7 5 
2 . 2 5 
3 . 6 6 
4 . 0 8 
± SD 
0 . 0 0 
0 .1 3 
0 . 1 3 
0 . 1 3 
0 . 3 4 
0 . 4 5 
0 . 2 2 
0 . 3 4 
0 . 3 4 
0 . 2 7 
0 . 2 8 
0 . 4 3 
0 . 5 4 
0 . 3 3 
0 . 6 4 
0 . 6 2 
0 . 2 0 
0 .1 3 
0 . 3 0 
0 . 1 3 
0 . 0 7 
0.3.0 
0 . 6 3 
0 . 6 9 
0 . 7 4 
0 . 6 5 
0 . 4 9 
0 . 6 1 
0 . 7 6 
0 . 7 0 
0 . 4 1 
0 . 8 1 
0 . 4 9 
0 . 7 7 
0 . 5 1 
0 . 5 4 
TABLIZ 5.9a : Shows liic mean value and Uie standard deviation for awaJcc period for every' 
bins before and after injection of DMSO (vehicle) 
5 mill 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 9 0 
M E A N 
2 . 7 5 
4 . 1 6 
4 . 5 0 
4 . 7 5 
4 . 5 0 
4 . 4 1 
4 . 8 3 
3 . 3 3 
3 . 5 8 
3 . 8 3 
3 . 5 0 
3 . 5 0 
4 . 2 5 
4 . 1 6 
3 . 6 6 
2 . 6 6 
4 . 0 0 
4 . 3 3 
± SD 
0 . 5 7 
0 . 2 3 
0 . 4 1 
0 . 1 4 
0 . 2 8 
0 . 2 2 
0 . 0 8 
0 . 8 6 
0 . 5 2 
0 . 6 1 
0 . 5 9 
0 . 6 7 
0 . 3 3 
0 . 4 5 
0 . 4 8 
0 . 6 5 
0 . 4 5 
0 . 3 6 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
1 0 0 - 1 0 5 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 25 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
M E A N 
5 . 0 0 
4 . 2 5 
3 . 7 5 
3 . 1 6 
1 . 5 0 
1 . 4 1 
0 . 5 0 
1 . 2 5 
1 . 2 5 
0 . 6 6 
0 . 0 0 
0 . 1 6 
1 . 3 3 
0 . 5 8 
0 . 0 0 
1 . 2 5 
1 . 0 0 
0 . 7 5 
0 . 5 0 
1 . 1 6 
1 . 1 6 
0 . 8 3 
1 . 1 6 
0 . 9 1 
1 . 1 6 
0 . 5 8 
1 ,9 1 
1 . 9 1 
0 . 9 1 
1 . 8 3 
1 . 0 0 
1 . 2 5 
0 . 9 1 
1 . 6 6 
3 . 0 0 
5 . 0 0 
± SD 
0 . 0 0 
0 . 6 1 
0 . 6 6 
0 . 6 7 
0 . 3 0 * • 
0 . 6 3 • 
0 . 1 8 - • 
0 . 7 0 * 
0 . 4 3 • • 
0 . 2 5 • • 
0 . 0 0 * • 
0 . 1 3 * • 
0 . 5 1 -
0 . 4 7 • • 
0 . 0 0 * • 
0 . 4 8 • 
0 . 2 8 ' • 
0 . 3 1 * • 
0 . 2 1 * • 
0 . 2 3 " • 
0 . 4 4 • • 
0 . 5 3 • • 
0 . 4 5 • 
0 . 3 0 * 
0 . 4 4 
0 . 3 4 • 
0 . 6 3 
0 . 5 7 
0 . 4 0 
0 . 5 7 
0 . 3 5 • • 
0 . 5 9 
0 . 3 2 * * 
0 . 6 2 
0 . 6 0 
0 . 0 0 
TABI.,!: 5.9b : Shows the mean value and Uie standard deviation for awake period for ever> 
bins before and after injection of yohimbine ' p < 0 05 •*p<0.01 
5 mm 
PREINJECTION POSTINJECTION 
TIME (Mini 
0 - 5 
5- 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 8 5 
8 5 9 0 
M E A N 
2 . 9 1 
2 . 1 6 
3 . 2 5 
3 . 3 3 
2 . 4 1 
3 . 2 5 
3 . 5 0 
3 . 1 9 
3 . 5 0 
3 . 8 3 
3 . 2 5 
2 . 5 0 
3 . 0 8 
2 . 7 5 
2 . 3 3 
3 . 3 3 
4 . 1 6 
3 . 8 3 
± SD 
0 . 6 3 
0 . 3 7 
0 . 4 8 
0 . 4 8 
0 . 2 4 
0 . 5 3 
0 . 3 6 
0 . 5 0 
0 . 5 0 
0 . 4 9 
0 . 6 0 
0 . 5 0 
0 . 5 9 
0 . 5 1 
0 . 7 4 
0 . 4 7 
0 . 2 9 
0 . 5 3 
TIME (Mini 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 6 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
65 7 0 
7 0 75 
75 8 0 
8 0 8 5 
8 6 9 0 
9 0 9 5 
95 1 0 0 
1 0 0 1 0 5 
1 0 5 - 1 10 
1 1 0 - 1 1 5 
1 1 5 1 2 0 
1 2 0 - 1 2 5 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
15 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
M E A N 
4 . 9 1 
4 . 4 1 
3 . 3 3 
3 . 4 1 
3 . 0 8 
3 . 8 3 
4 . 4 1 
3 . 6 6 
3 . 58 
3 . 9 1 
4 . 1 6 
3 . 6 6 
3 . 4 1 
3 . 5 0 
2 . 5 8 
3 . 3 3 
4 . 6 6 
3 . 4 1 
3 . 7 5 
4 . 0 8 
3 . 4 1 
2 . 8 3 
3 . 0 0 
2 . 4 1 
2 . 2 5 
1 . 5 8 
0 . 9 1 
2 . 1 6 
2 . 1 6 
2 . 1 6 
3 . 5 8 
2 . 8 3 
2 . 9 1 
1 . 7 5 
3 . 0 0 
3 . 4 1 
± SD 
0 . 0 7 
0 . 2 2 
0 . 5 2 
0 . 5 7 
0 . 6 9 
0 . 5 8 
0 . 3 0 
0 . 3 3 
0 . 7 0 
0 . 4 7 
0 . 3 4 
0 . 4 2 
0 . 6 0 
0 . 3 3 
0 . 5 5 
0 . 6 9 
0 . 2 0 
0 . 4 9 
0 . 4 7 
0 . 3 0 
0 . 5 9 
0 . 6 5 
0 . 7 3 
0 . 7 9 
0 . 7 3 
0 . 6 1 
0 . 4 0 
0 . 6 9 
0 . 7 6 
0 . 7 6 
0 . 4 7 
0 . 7 7 
0 . 6 9 
0 . 6 3 
0 . 5 3 
0 . 5 6 
TAHLE 5.10a : Shows tlie mean value and the standard deviation for Active Wakcl'ulnes.s (Wl) for 
every' 5 min bins before and after injection of DMSO (vehicle) 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
2 5-30 
3 0-35 
3 5-40 
4 0-45 
4 5-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85 90 
M E A N 
1 .83 
3.66 
4.41 
3.91 
3.00 
3.58 
4.08 
3.16 
3.08 
2.83 
2.58 
3.00 
3.66 
3.08 
2. 1 6 
1 .25 
2.33 
2.50 
± SD 
0.69 
0.42 
0.40 
0.35 
0.68 
0.65 
0.46 
0,82 
0.61 
0.81 
0,74 
0,75 
0.47 
0.59 
0.42 
0.62 
0.58 
0.61 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80 85 
85-90 
90-95 
95-100 
1 00-105 
1 0:5 1 1 0 
11 0 - 1 1 5 
1 15-120 
1 20-1 25 
1 2 5-1 30 
13 0-135 
13 5-140 
1 40-1 45 
145-1 50 
1 50-1 55 
1 55-160 
16 0-165 
165-1 70 
170-1 75 
1 75-1 80 
M E A N 
4.58 
3.00 
3.08 
1.91 
0.83 
1.16 
0.25 
0.83 
0.75 
0.50 
0.00 
0. 16 
0.75 
0.58 
0.00 
1.16 
0.50 
0.58 
0.4 1 
0.83 
0.58 
0.4 1 
0.66 
0.50 
1 .00 
0.4 1 
1 .58 
1 .08 
0.25 
1 .00 
0.7 5 
0,6 6 
0.50 
1.16 
1 .41 
2.41 
± SD 
0.27 
0.67 
0.68 
0.63 
0.31 * 
0.65' 
0. 1 4* • 
0.68' 
0.39* 
0.2 1 • • 
0.00* • 
0. 1 3 • • 
0.23* * 
0.47* • 
0.00* • 
0.50* 
0.21 • • 
0.32" • 
0. 1 9* • 
0.23 • • 
0.24* • 
0.34* 
0.29* 
0.2 1 
0.42 
0.34* 
0.69 
0.44 
0.14' 
0.46 
0.31 • • 
0.47 
0.28' 
0.49 
0.44* 
0.72 
TABI.,!: 5.10b : Shows the meaii value and Uic sUuidard deviation for Active Wakefulness (Wi 
every 5 min bins before and afler injection of yohimbine * p < 0 05 •• p < 
)lor 
0.01 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 6 5 
6 5 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 9 0 
M E A N 
1 . 2 5 
1 . 8 3 
1 . 0 0 
1 . 0 8 
1 . 7 5 
0 . 8 3 
1 . 1 6 
0 . 5 8 
1 . 1 6 
0 . 4 1 
0 . 4 1 
1 . 1 6 
0 . 5 8 
1 . 1 6 
0 . 7 5 
0 . 7 5 
0 . 8 3 
0 . 4 1 
± SD 
0 . 5 3 
0 . 4 3 
0 . 3 1 
0 . 3 5 
0 . 3 7 
0 . 2 7 
0 . 3 7 
0 . 1 9 
0 . 3 7 
0 . 1 2 
0 . 1 2 
0 . 5 0 
0 . 2 7 
0 . 3 9 
0 . 3 9 
0 . 3 3 
0 . 2 9 
0 2 2 
TIME (Min) 
0 - 6 
5 -1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 7 0 
7 0 75 
7 5 - 8 0 
8 0 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
1 0 0 - 1 0 5 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 2 5 
12 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
16 5 - 1 7 0 
1 7 0 - 1 7 6 
17 5 - 1 8 0 
M E A N 
0 . 0 8 
0 . 4 1 
1 . 5 0 
1.4 1 
0 . 8 3 
0 . 4 1 
0 . 1 6 
0 . 7 5 
0 . 8 3 
0 . 6 6 
0 . 3 3 
0 . 5 0 
0 . 2 5 
0 . 4 1 
1 . 1 4 
0 . 5 8 
0 . 0 8 
1.4 1 
0 . 6 6 
0 . 7 5 
1 . 5 0 
1 . 1 6 
0 . 5 0 
0 . 4 1 
0 . 5 8 
0 . 5 8 
1 . 0 8 
0 . 6 6 
0 . 5 8 
0 . 4 1 
0 . 5 0 
0 . 1 6 
0 . 8 3 
0 . 8 3 
0 . 6 6 
0 . 6 6 
± SD 
0 . 0 7 
0 . 1 6 
0 . 5 5 
0 . 4 6 
0 . 3 7 
0 . 1 6 
0 . 0 8 
0 . 2 5 
0 . 5 2 
0 . 2 5 
0 . 1 3 
0 . 2 1 
0 . 1 4 
0 . 1 2 
0 . 6 7 
0 . 2 7 
0 . 0 7 
0 . 5 1 
0 . 2 3 
0 . 3 3 
0 . 5 6 
0 . 5 0 
0 . 3 3 
0 . 3 4 
0 . 2 7 
0 . 2 7 
0 . 2 4 
0 . 2 0 
0 . 3 4 
0 . 1 6 
0 . 2 6 
0 . 1 3 
0 . 2 3 
0 . 4 4 
0 . 2 9 
0 . 2 5 
TABLE 5.11a : Shows the mean value aiid ihe slaiiciard deviation for Quiet Waketulnes.s (W2) for 
ever)' 5 min bins before and after injection of DMSO (vehicle) 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-1 5 
15-20 
20-25 
2 5-30 
30-35 
35-40 
4 0-45 
4 5-50 
5 0-55 
5 5-60 
6 0-65 
6 5-70 
7 0-75 
7 5-80 
80-85 
85-90 
M E A N 
0.91 
0.50 
0.08 
0.83 
1.50 
0.83 
0.75 
0.16 
0.50 
1 .00 
0.91 
0.50 
0.58 
1 .08 
1 .5,0 
1 .25 
2.08 
1 .75 
« 
± SD 
0.29 
0.28 
0.07 
0.25 
0.46 
0.53 
0.47 
0.08 
0.10 
0.59 
0.38 
0.26 
0.30 
0.40 
0.28 
0.59 
0.28 
0.44 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80 85 
85-90 
90-95 
9-5-100 
100-105 
105-1 10 
110-115 
115-120 
1 20-1 25 
1 25-1 30 
130-135 
13 5-14-0 
1 40-145 
145-1 50 
150-155 
155-160 
160-165 
165-170 
1 70-1 75 
17 5-180 
M E A N 
0.41 
1 .25 
0.66 
1.25 
0.66 
0.25 
0.25 
0.41 
0.50 
0.1 6 
0.00 
0.00 
0.58 
0.00 
0.00 
0.08 
0.50 
0. 1 6 
0.08 
0.33 
0,58 
0.41 
0.50 
0.41 
0.1 6 
0.1 6 
0.33 
0.83 
0.66 
0.83 
0.25 
0.58 
0.41 
0.50 
0.75 
1.75 
± SD 
0.27 
0.48 
0.33 
0.34 
0.25 
0.14 
0.14 
0.34 
0.33 
0.08 
0.00 
0.00 
0.32 
0.00* 
0.00 
0.07 
0. 1 8 
0.13* 
0.07* 
0. 1 3 
0.30 
0.22 
0.28 
0.19 
0.1 3 
0. 1 3 
0.17* 
0.23 
0.40 
0.37 
0.20 
0.40 
0.12 
0.28 
0.39 
0.28 
TABLE 5.11b : Shows the mean value and the staiidard deviation for Quiet Wakefulness (W2) for 
every 5 min bins before and after injection of yohimbine • p < 0.05 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
M E A N 
0.66 
1 .00 
0.75 
0.58 
0.83 
0.91 
0.33 
0.50 
0.33 
0. 7 5--
1 .25 
1 .33 
1 .33 
0.91 
1 .83 
1 .00 
0.08 
0.91 
± SD 
0.47 
0.48 
0.39 
0.30 
0.37 
0.41 
0.20 
0.33 
0.1 3 
0.39 
0.59 
0.59 
0.69 
0.45 
0.50 
0.42 
0.07 
0.54 
TIME (Min) 
0-5 
5-1 0 
1 0-1 5 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
8 5 9 0 
90-35 
95-100 
1 00-1 05 
10 5-1 10 
110-115 
115-120 
12 0-125 
125-130 
1 30-1 35 
135-140 
1 40- 1 45 
1 45-1 50 
1 50-1 55 
155-160 
1 60-1 65 
165-170 
1 70-1 75 
1 75-1 80 
M E A N 
0.00 
0.16 
0.16 
0. 1 6 
1 .08 
0.75 
0.41 
0.58 
0.58 
0.41 
0.50 
0.83 
1 .33 
1 .08 
1 .00 
1 .00 
0.25 
0.16 
0.5 8 
0.16 
0.08 
1 .00 
1.50 
1.9 1 
2.00 
2.58 
2.25 
2.00 
1 .4 1 
1.83 
0.91 
1 .50 
1.16 
2.66 
1 .25 
0.75 
± SD 
0.00 
0. 1 3 
0. 1 3 
0. 1 3 
0.34 
0.45 
0.22 
0.34 
0.34 
0.27 
0.28 
0.43 
0.54 
0.37 
0.41 
0.56 
0.20 
0.13 
0.30 
0.13 
0.07 
0.30 
0.63 
0.63 
0.68 
0.57 
0.48 
0.59 
0.46 
0.52 
0.41 
0.66 
0.45 
0.74 
0.47 
0.42 
TABLl: 5.12a : Shows the mean value and Uie standard deviation for Light Slow Wave sleep (SI) for 
every 5 niin bins before and after injection of DMSO (vehicle) 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 9 0 
M E A N 
2 . 2 5 
0 . 8 3 
0 . 5 0 
0 . 2 5 
0 . 5 0 
0 . 5 8 
0 . 1 6 
1 . 1 6 
1 . 4 1 
1 . 1 6 
1 . 5 0 
1 . 5 0 
0 . 7 5 
0 . 8 3 
1 . 3 3 
2 . 3 3 
1 . 0 0 
1 . 0 8 
± SD 
0 . 5 7 
0 . 2 3 
0 . 4 1 
0 . 1 4 
0 . 2 8 
0 . 2 2 
0 . 0 8 
0 . 8 6 
0 . 5 2 
0 . 6 1 
0 . 5 9 
0 . 6 7 
0 . 3 3 
0 . 4 5 
0 . 4 8 
0 . 6 5 
0 . 4 5 
0 . 4 1 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 95 
9 5 1 0 0 
1 0 0 1 0 5 
1 0 5 - 1 10 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 1 2 5 
1 2 5 - 1 3 0 
13 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
M E A N 
0 . 0 0 
0 . 7 5 
1 . 2 5 
1 . 8 3 
3 . 5 0 
3 . 3 3 
4 . 0 8 
3 . 5 8 
3 . 5 0 
4 . 0 8 
4 . 5 8 
3 . 6 6 
2 . 9 1 
3 . 5 8 
3 . 2 5 
2 . 8 3 
3 . 1 6 
3 . 2 5 
2 . 5 8 
2 . 2 5 
2 . 7 5 
3 . 4 1 
3 . 0 0 
3 . 0 0 
2 . 6 6 
2 . 7 5 
2 . 0 8 
2 . 8 3 
3 . 7 5 
2 . 7 5 
2 . 8 3 
2 . 9 1 
3 . 3 3 
3 . 0 0 
2 . 7 5 
0 . 8 3 
± SD 
0 . 0 0 
0 . 6 1 
0 . 6 6 
0 . 6 7 * 
0 . 3 0 * • 
0 . 5 7 * 
0 . 2 7 • • 
0 . 6 7 • 
0 . 4 2 * • 
0 . 2 7 • • 
0 . 2 7 • • 
0 . 3 7 • • 
0 . 4 1 • 
0 . 4 4 • • 
0 . 4 8 • 
0 . 6 9 • 
0 . 3 4 • • 
0 . 4 3 • • 
0 . 4 3 • 
0 . 2 7 • • 
0 . 3 4 • • 
0 . 4 6 • • 
0 . 3 8 • 
0 . 2 8 
0 . 4 4 
0 . 4 3 
0 . 5 3 
0 . 4 9 
0 . 3 4 * • 
0 . 4 9 
0 . 2 5 • • 
0 . 4 0 
0 . 3 1 • 
0 . 5 4 
0 . 6 1 
0 . 6 8 
TAIiiLE 5 12b : Shows the mean value and the sUuidard deviation for Light Slow Wave sleep (S1) for 
every 5 min bins before and al\er injection og yohimbine • p < 0.05 ** p < 0.01 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-1 0 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70 75 
75-80 
80-85 
85 90 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
TIME (Min) 
0-5 
5-10 
10-1 5 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95 1 00 
1 00-105 
105-110 
110-115 
115-120 
1 20-1 25 
1 25-1 30 
1 30-1 35 
1 35-140 
1 40-1 45 
1 45-1 50 
1 50-1 55 
1 55-1 60 
1 60-1 65 
165-1 70 
1 70-1 75 
1 75-1 80 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0. 1 6 
0.08 
0.2 5 
0.66 
0. 1 6 
0.58 
0.41 
0.00 
0.25 
0.00 
0.83 
0.00 
0.00 
.t SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0. 1 3 
0.07 
0. 1 4 
0.40 
0.08 
0.30 
0.34 
0.00 
0.20 
0.00 
0.07 
0.00 
0.00 
TABLE 5.13a : Shows the nean value and the standard deviation for Deep Slow Wave sleep (S2) for 
every 5 min bins before and after injection of DMSO (vehicle) 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
M E A N 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0.00 
0 . 0 0 
0 . 0 0 
0 . 0 0 
± SD 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0.00 
0 . 0 0 
0 . 0 0 
0 . 0 0 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 1 0 0 
1 0 0 - 1 0 5 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 2 5 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
M E A N 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 1 6 
0 . 3 3 
0 . 1 6 
0 . 1 6 
0 . 0 8 
0 . 4 1 
1 . 0 0 
0 . 5 8 
0 . 5 8 
1 .00 
0 . 7 5 
0 . 8 3 
1 . 0 0 
1 . 5 8 
1 . 5 0 
1 . 0 0 
0 . 5 8 
0 . 7 5 
0 . 9 1 
1 . 0 0 
1 . 5 0 
0 . 8 3 
0 . 2 5 
0 . 1 6 
0 . 2 5 
1 . 0 8 
0 . 8 3 
0 . 5 0 
0 . 3 3 
0 . 0 0 
0 . 0 0 
± SD 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 8 
0 . 2 0 
0 . 1 3 
0 . 1 3 
0 . 0 7 
0 . 2 7 
0 . 3 3 • 
0 . 2 7 
0 . 3 4 
0 . 3 1 -
0 . 3 9 
0 . 4 0 
0 . 5 3 
0 . 5 5 • 
0 . 4 1 • • 
0 . 3 0 • 
0 . 2 4 • 
0 . 2 9 
0 . 8 5 
0 . 4 2 • 
0 . 4 9 * 
0 . 3 1 
0 . 2 0 
0 . 1 3 
0 . 2 0 
0 . 2 4 * • 
0 . 2 7 
0 . 2 8 
0 . 1 3 
0 . 0 0 
0 . 0 0 
TABLE 5.13b ; Shows the mean value and the standard deviation for Deep Slow Wave sleep (S2) lor 
every 5 min bins before and after injection of yohimbine ' p < 0 05 •* p < 0.01 
PREINJECTION POSTINJECTION 
TIME (Min) 
0-5 
5-10 
10-15 
1 5-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
M E A N 
0.1 6 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.08 
0.00 
0.00 
0.16 
0.08 
0.08 
0-00 
0.00 
' 
± SD 
0.1 3 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.07 
0.00 
0.00 
0. 1 3 
0.07 
0.07 
0.00 
0.00 
TIME (Min) 
0-5 
5-10 
10-15 
15-20 
20-25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60-65 
65-70 
70-75 
75-80 
80-85 
85-90 
90-95 
95-1 00 
100-105 
105-1 10 
110-115 
1 1 5-120 
120-125 
1 25-1 30 
1 30-1 35 
1 35-1 40 
1 40-1 45 
1 45-1 50 
1 50-1 55 
1 55-1 60 
160-165 
1 65-1 70 
1 70-1 75 
175-180 
M E A N 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.08 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.08 
0.08 
0.00 
0.08 
0.00 
0.25 
0. 1 6 
0.00 
0.25 
0.08 
0,00 
0.08 
0.16 
± SD 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.07 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.07 
0.07 
0.00 
0.07 
0.00 
0.20 
0. 1 3 
0.00 
0.20 
0.07 
0.00 
0.07 
0.13 
TABLIi 5.14a : Shows the mean value and Iha standard deviation for Paradoxical Sleep (PS) for 
every 5 mm bins before and afler mjection of DMSO (Vehicle) 
PREINJECTION POSTINJECTION 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 8 5 
8 5 - 9 0 
M E A N 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
± SD 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 , 0 0 
0 . 0 0 
0 . 0 0 
TIME (Min) 
0 - 5 
5 - 1 0 
1 0 - 1 5 
1 5 - 2 0 
2 0 - 2 5 
2 5 - 3 0 
3 0 - 3 5 
3 5 - 4 0 
4 0 - 4 5 
4 5 - 5 0 
5 0 - 5 5 
5 5 - 6 0 
6 0 - 6 5 
6 5 - 7 0 
7 0 - 7 5 
7 5 - 8 0 
8 0 - 8 5 
8 5 - 9 0 
9 0 - 9 5 
9 5 - 1 0 0 
10 0 - 1 0 5 
1 0 5 - 1 1 0 
1 1 0 - 1 1 5 
1 1 5 - 1 2 0 
1 2 0 - 1 2 5 
1 2 5 - 1 3 0 
1 3 0 - 1 3 5 
1 3 5 - 1 4 0 
1 4 0 - 1 4 5 
1 4 5 - 1 5 0 
1 5 0 - 1 5 5 
1 5 5 - 1 6 0 
1 6 0 - 1 6 5 
1 6 5 - 1 7 0 
1 7 0 - 1 7 5 
1 7 5 - 1 8 0 
M E A N 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 8 
0 . 0 8 
0 . 0 0 
0 . 0 8 
0 . 1 6 
0 . 0 0 
0 . 1 6 
0 . 1 6 
0 . 2 5 
0 . 7 5 
0 . 1 6 
0 . 0 0 
0 . 0 0 
0 . 3 3 
0 . 0 8 
0 . 0 8 
0 . 1 6 
0 . 0 8 
0 . 1 6 
0 . 1 6 
0 . 1 6 
0 . 1 6 
0 . 0 0 
0 . 1 6 
0 . 1 6 
0 . 0 8 
0 . 0 0 
0 . 2 5 
0.00 
0 . 0 8 
0 . 0 0 
± SD 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 0 
0 . 0 7 
0 . 0 7 
0 . 0 0 
0 . 0 7 
0 . 1 3 
0 . 0 0 
0 . 1 3 
0 . 0 8 
0 . 1 4 
0 . 1 4 ' 
0 . 0 8 
0 . 0 0 
0 . 0 0 
0 . 1 3 
0 . 0 7 
0 . 0 7 
0 . 0 8 
0 . 0 7 
0 . 0 8 
0 . 0 8 
0 . 1 3 
o:o8 
0 . 0 0 
0 . 0 8 
0 . 1 3 
0 . 0 7 
0 . 0 0 
0 . 1 4 
0.00 
0 . 0 7 
0 . 0 0 
TABLI- 5.14b : Shows the mean value and the standard deviation for Paradoxical Sleep (PS) for 
every 5 min bins before and aller injection of yohimbine * p < 0.05 
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DISCUSSION 
This study was undertaken to find out the role of 
alpha-2 receptors in the mPOA in the regulation of sleep-
wakefulness. The alpha-2 agonist and antagonist were locally 
applied at the mPOA, through intracerebral administration, in 
free moving rats. The arousal produced by the administration 
of clonidine (alpha-2 agonist) and sleep induced by yohimbine 
(alpha-2 antagonist) are discussed, after giving some 
justification for the techniques employed. 
Techniques employed in the study 
Intracerebral injection study is extremely useful in 
understanding the heterogeneoas functions of different 
regions of the brain and also for identifying the receptors 
and transmitters involved in various regulatory functions. 
Strict precautions were observed and adhered to when 
performing these studies to minimize trhe limitations of this 
technique. First of all, the experiments were carried out 
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only after the animals had completely recovered from the 
surgical trauma. No animal was used for more than one 
injection. The volume of the drug injected was kept at 0.2 
ul, which is very small and it would produce least amount of 
destruction of the injection site (Rottenberg, 1970), The 
animals were handled gently while performing the injection, 
so that it would not be disturbed. 
Unlike many earlier reports, where S-W was analysed 
into two or three stages only (Timo-Iaria et al., 1970), we 
have analysed the sleep-awake states into five different 
distinct stages (John et al., 1994). This gives us an 
opportunity to see how the components of S-W are affected by 
the drug. 
Long periods of preinjection record (for 90 min) were 
taken in this study to minimize the preinjection bias. This 
is in contrast to shorter preinjection records taken in the 
earlier studies (Mohan Kumar et al 1984, 1986; Mallick and 
Alam, 1992) . This long period of preinjection record has 
given a good set of control values, which can be compared 
with post injection readings. 
The postinjection recording of 180 min not only 
provides an opportunity for finding out the time course of 
action of any drug, but also provides a scope for observing 
some latent effects which would be missed in shorter periods 
of recording. 
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Modulation of sleep-va)cefulnes3 by alpha-2 adrenoceptors 
The results from this study showed that the injection 
of clonidine, an alpha-2 agonist, at the level of mPOA 
produced arousal or wakefulness. When different components of 
wakefulness were analysed, it was found that the increased 
wakefulness was due to a change in W2 rather than Wl. From 
the analysis of different components of wakefulness, it was 
possible to see that the effect of clonidine was to increase 
quiet wakefulness. It was noted, that the rats, after 
clonidine administration, had wide open eyes and were 
stationary most of the time. The results of the study showed 
that clonidine, through increased wakefulness, did not 
produce any alteration in activity.. In other words, there was 
a dissociation between sleep and activity, though both of 
them could be regulated by the mPOA. Dissociation between S-W 
and activity was also reported after adm.inistration of 5-HT 
(Datta et al., 1987). Similarly, SI component of sleep "was 
affected by alpha-2 agonist administration, i.e., SI was 
significantly decreased. S2 and PS were not a-ffacted by 
clonidine administration into the mPOA. 
Injection of yohimbine, an.alpha-2 antagonist induced 
sleep. The total sleep time was analysed into its different 
components. The injection bound sleep was due to an increase 
in SI. During tha latter part of the recording time, S2 
showed increase in continuous bins. Deep slow wave sleep (S2) 
usually appears after the rat has spent considerable time in 
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light slow wave sleep (SI) . PS was normal and was not 
affected by the injection of yohimbine. We can thus state 
that yohimbine induced sleep does not affect the PS 
regulatory mechanism. On the other hand, it triggers that 
neuronal circuitry which controls the slow wave sleep (both 
light and deep stages). Unlike as in the clonidine group, Wl 
stage was the one which was affected by yohimbine. 
The study thus confirms not only the importance of the 
mPOA, a basal forebrain structure, in the regulation of sleep 
and wakefulness, but also the involvement of the 
noradrenergic system, which projects to the mPOA via the VNA. 
The probable mechanisms for these injection bound alteration 
in S-W are discussed below. 
Earlier studies showed that the injection of NE at the 
raPOA produces arousal (Datta et al., 1988; Mohan Kumar et 
al., 1984; Mohan Kumar et al., 1986). It was previously 
suggested that the arousal response resulted from the action 
of NE on the postsynaptic receptors (Mohan Kumar et al., 
1986) . Later, it was shown that the administrairion of NE 
induced sleep when presynaptic receptors were removed from 
the mPOA (by administration of 6-Hydroxydopamine) . In these 
preparations, postsynaptic receptors were only available for 
the action of the drug (Mohan Kumar et al., 1993). These 
findings indicate that the arousal produced in normal animals 
might have resulted from the action of NE on alpha-2 
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receptors (in the NE terminals) , which in turn would have 
resulted in the decreased release of NE. This assumption is 
further supported by the findings in the present study, in 
which the alpha-2 agonist, clonidine, also produced arousal. 
Clonidine injection into the mPOA, results in the 
activation of alpha-2 receptors at the presynaptic membrane, 
causing a decreased release of endogenous NE. Thus, it 
further clarifies the role of adrenergic receptors at the 
mPOA in the modulation of sleep-wakefulness. Yohimbine, an 
alpha-2 antagonist, which blocks the presynaptic receptors 
and facilitates the release of NE, induces sleep. These 
results also indicate that the normal function of NE 
terminals at the mPOA, is induction of sleep. 
The sleep induced by yohimbine resembled normal sleep 
in all respects. The slow wave sleep was interposed, at 
times, with PS though there was no significant increase in 
this c-ojnponent of sleep. But th« wakefulness pjrodoiced by 
clonidine, cannot be described as a normal state. In addition 
to the EEG dissociation, other changes like dilated pupil 
make it difficult to be considered a^ a normal waJcefulness. 
Clonidine produce EEG synchronLzation with eyes open even 
after intraventricular injection (Holman et al., 1971). 
Though the alpha-2 receptors are predominajitly present 
on presynaptic membrane, it should be noted that some alpha-2 
receptors, which are the primary sites of action of clonidine 
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and yohimbine, are found on postsynaptic membrane and in 
glial cells also (Arbilla and Langer, 1990; Bockaert et al., 
1990). It is possible that the drugs administered at the 
mPOA, might act on these receptors. The glial-neuronal 
interaction may be also contributing towards some of the 
observed responses. 
The cortical synchronization might be resulting from an 
alteration of the firing of cortical neurons, through already 
demonstrated preoptico-cortical connections (Canedo et al., 
1978; Palkovitz and Zaborszky, 1979). The synchronized EEG 
waves, obtained after injection of clonidine, might have been 
responsible for the earlier report which claimed that this 
drug induced sleep, when given at the mPOA during night 
(Mallick and Alam, 1992) . It is difficult to explain the 
reasons why yohimbine produced opposite effects in their 
study. 
The significant alteration of sleep and wakefulness, in 
discontinuous bins, may not be due to the effect ojf drug 
injection. These changes cou^Id be attributed to tlie 
coincidence of random changes due to inrherent polycyclic 
sleep pattern of rats. Hence they were not given importrance. 
It can be concluded that the activation of alpha-2 
adrenergic receptors at the mPOA induces wakefulness, where 
as its blocker produces sleep. These observations show that 
these receptors, which are mainly presynaptic in location, 
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are involved in the arousal response or wakefulness. The 
findings also help to clarify some of the earlier reports 
where adrenergic agonists applied at the ^mPOA, have produced 
arousal. 
CHAPTER 7 
SUMMARY AND CONCLUSIONS 
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SUMMARY AND CONCLUSIONS 
1. It is now well established that the mPOA plays an 
important role in the regulation sleep-wakefulness. The 
available literature also suggests that noradrenergic 
system is involved in this regulation. 
2. The present study was undertaken to investigate the 
role of alpha-2 adrenoceptors in the regulation of 
sleep-wakefulness at the level ol mPOA. 
3. This study was oonducted on four groups of adult male 
Wistar rats. 
4. Studies were carried out on freely moving rats and 
sleep-wakefulness was assessed on the basis of EEG, EMG 
and EOG recordings along with visual behaviour 
observation. Drugs were applied in the mPOA through 
chronically indwelling cannulae. 
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5. The preinject ion values obtained from d i f fe ren t animals 
of each group, did not show any s ign i f ican t d i f ference, 
i n d i c a t i n g t h a t the r a t s wi thin each group were 
comparable. 
6. Inject ion of clonidine, an alpha-2 agonist , a t the mPOA 
produced a r o u s a l . Behaviour a rousa l produced by 
clonidine administration was accompanied by increased 
EMG and EOG a c t i v i t i e s . These r a t s had wide open eyes 
with d i la ted pupi ls . During t h i s period they showed 
decreased a c t i v i t y . Thus, quiet wakefulness (W2) was 
s ign i f i can t ly increased by clonidine adminis t ra t ion . 
There was a paradoxical increase in EEG synchronization 
during t h i s period. 
7. Yohimbine, an alpha-2 antagonist, when injected in to 
t he mPOA ixrdixced s l e e p . There was a s i g n i f i c a n t 
increasje in SJ. and S2 stages as compared to i t s control 
group. 
8 . C l o n i d i n t e i n j e c t i o n intx> t h e mPOA, r e s u l t s i n t h e 
a c t i v a t i o n o f a lph-a-2 r e c e p t o r a t t h e p r e s y n a p t i c 
t e r j n i n a l caus ing : d e c r e a s e d r e l e a s e of endogenous NE. 
T h i s n o n - a v a i l a b i l i t y of endogenous NE, l e a d i n g t o a 
d e c r e a s e d a c t i o n o n , t h e p o s t s y n a p t i c m e m b r a n e , 
p roduced a r o u s a l r e s p o n s e . 
'S.V. . ^ 
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9. Yohimbine blocks the presynaptic alpha-2 receptors 
(decreases the action of endogenous NE on these 
receptors) facilitates the release of NE. This in turn 
acts on the postsynaptic membrane to induce sleep. 
10. Presynaptic alpha-2 receptors are involved in the 
arousal response or wakefulness. We hypothesize that 
the normal function of NE terminal at the level of 
mPOA, is induction of sleep, rather than arousal. 
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